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ABSTRACT 
 
Aims: The aims of this research were to describe the signs and symptoms of dysphagia in 
people who are living with HIV/AIDS and to see what participant variables such as CD4 
count, age and diagnosis affect dysphagia.   
Methods: This study was a descriptive, cross-sectional, quasi non-experimental design. The 
sampling method that was used for this research was non-probability and convenient. These 
patients were referred to the speech therapy and audiology department from various 
multidisciplinary team members for dysphagia assessments. There were 106 participants in 
total. Eighty participants underwent only a clinical bedside assessment and 26 underwent a 
bedside assessment as well as a modified barium swallow. The Mann Assessment of 
Swallowing Ability (MASA) was used to conduct the clinical bedside assessments and a 
modified barium swallow (MBS) was used as an objective measure. The data was analysed 
using both descriptive and inferential statistics. These tests included the Wilcoxon signed 
rank test, Spearman Rho test, Kruskal-Wallis and Mann Whitney U-test.  
Results: Descriptively, the results revealed that participants with  neurological conditions 
appeared to present with more severe signs and symptoms of dysphagia. The results from the 
Wilcoxon signed rank test showed that participants with a neurological disorder experienced 
more severe signs and symptoms of dysphagia, except with laryngeal elevation. The 
Wilcoxon signed rank test also showed that older participants experienced more dysarthria 
and oral transit difficulties. The results from the Kruskal-Wallis test highlighted that 
participants with a lower CD4 count had more significant respiration and voice difficulties. 
The results from the Mann-Whitney U test showed that participants who were on a HAART 
regimen experienced increased difficulty in the pharyngeal phase and aspirated more 
frequently. The Spearman-Rho test results showed that the MASA was seen as a valid 
bedside assessment tool for assessing adult dysphagia in an acute hospital setting.  
Discussions: Dysphagia does occur in the HIV/AIDS population in South Africa in 
participants who have neurological conditions as well as opportunistic infections. The SLP 
needs to play a key role in the assessment and management of these patients. The MASA is a 
good assessment tool to use in settings where objective measures are not available.  
Keywords: dysphagia – assessment - HIV/AIDS- speech language therapist/pathologist 
(SLT/P) – Mann Assessment of Swallowing Ability – Modified Barium Swallow – South 
Africa.  
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1. INTRODUCTION 
1.1. Introduction to HIV/ AIDS and the AIDS Epidemic  
HIV/AIDS can cause numerous complications within the body which can affect how it 
functions. One of these complications is how HIV/AIDS can affect a person’s ability to 
swallow. The swallowing process starts when the person places food in their mouth and ends 
as the food enters the oesophagus (Logemann, 1997). As swallowing is a continuous process, 
it can be affected at one or more stages. HIV/AIDS can affect an individual’s swallowing 
ability in different ways, for example through various opportunistic infections, as a side effect 
from Highly Active Antiretroviral Therapy (HAART) and from the treatments from various 
opportunistic infections for instance: radiation to treat Kaposi Sarcoma (Adedigba, Jeboda, 
Naidoo, and Ogunbodede, 2008). 
 
Millions of people worldwide have become infected with HIV/AIDS and it is now an 
epidemic. AIDS is considered to be a collection of numerous conditions that manifest 
themselves in the body (UNAIDS, 2009). HIV is the Human Immunodeficiency Virus which 
invades a human’s immune system and results in the immune system becoming less effective, 
therefore becoming vulnerable to opportunistic infections ( Conner, Fan & Villarreal, 2007). 
AIDS stands for Acquired Immune Deficiency Syndrome which occurs when a person’s 
immune system can no longer fight off infection due to HIV (Van Dyk, 2008). According to 
the United Nations (2009) the majority of people in Africa who are affected with HIV are 
adults who fall within the working class. HIV is negatively impacting Africa’s economy 
because people who should be working can no longer do so due to their illnesses (UNAIDS, 
2009). HIV/AIDS is also having a negative effect on Africa’s social systems because the 
majority of people who are dying from the AIDS epidemic are adults and this is resulting in 
millions of orphans, especially in Africa. As a result of this, it is turning families into child 
headed or grandparent headed households (UNAIDS, 2009).  Sub-Sahara is home to the 
largest portion of the world’s HIV/AIDS population. However, South Africa continues to be 
the country that has the largest portion of the world’s HIV/AIDS population – 5.6 million 
people (UNAIDS, 2010). As a result of all of these factors, HIV/AIDS is currently one of the 
major challenges facing South Africa today (UNAIDS, 2009).  
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Quite a lot of research looking at the relationship between HIV/AIDS and dysphagia has been 
conducted. Most other studies have been conducted by professionals other than speech – 
language pathologists (SLPs) (Anteyi, Idoko, Thatcher & Yohanna, 2003). These 
professionals mainly included dentists and periodontists (Anteyi et. al, 2003; Scannapieco, 
1999). These professionals have mostly gathered the data for their studies by using clinical 
oral examinations as well as biopsies that were analysed in a laboratory in order to confirm 
the diagnoses and questionnaires or radiographic studies (Daly, 2004; Halvorsen, Kearney & 
Moelleken, 2003). Most studies focused on oral manifestations present in adults living with 
HIV/AIDS (Anteyi et.al., 2003; Anup, Doshi,  Pai, Sharma, Suhas & Ramapuram, 2006; 
Besige, et. al, 2007). Consequently swallowing difficulties have mainly been inferred from 
the presenting symptomatology rather than those actually assessed.  Research looking at the 
relationship between HIV/AIDs and dysphagia has been conducted in developing countries 
such as Nigeria, Uganda and India (Anteyi et.al, 2003; Anup, et. al, 2006; Besige, et. al, 
2007).There is currently very little research that speaks to the South African population from 
a speech language therapist’s perspective. There is evidence from one South African study 
which concluded that there are different causes of dysphagia in a patient living with 
HIV/AIDS and how dysphagia affects an individual’s quality of life (Daly, 2004). However, 
this study only utilised a questionnaire and looked at participants who were outpatients (Daly, 
2004). Most of the studies that were done in developing countries were conducted using 
clinical oral examinations or subjective and objective measures (Anup et. al, 2006), whereas 
developing countries utilised radiographic instrumentation or objective assessments. There 
are currently no published research studies conducted by speech pathologists within South 
Africa (or other developing nations) that describe the swallowing difficulties that are 
experienced by adults who are living with HIV/AIDS by using subjective and objective 
measures. In addition, there are no specific signs and symptoms that have been documented 
and therefore no profile has been developed which describes how dysphagia presents in 
patients with HIV/AIDS. As mentioned above, the majority of HIV infected people (5.7 
million) in the world reside in South Africa. Consequently, the current research becomes very 
pertinent as many SLP’s practicing in South Africa work in under resourced health settings 
that do not allow for the expensive objective measures to be used. It is imperative that 
information be collected regarding on how reliable clinical examinations or subjective 
measures can be. The current study was therefore conducted at a regional adult only public 
sector hospital in Johannesburg, South Africa. The fact that the current study was conducted 
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within a hospital context allowed for utilisation of both clinical and objective measures 
during data collection. 
 
The purpose of this research was to assess the swallowing abilities of adults with HIV/AIDS 
by utilising both clinical (bedside assessment) and objective (modified barium swallow) 
measures and to describe their signs and symptoms of dysphagia.  
 
The following questions were asked: 
1.2. Research Questions  
1.2.1. What were the clinical signs and symptoms of dysphagia in a group of adult in-
patients living with HIV/AIDS? 
1.2.2. Was there a difference between the obtained signs and symptoms in patients with 
different medical histories (specifically these with neurological versus opportunistic 
infections)?  
1.2.3. Did a relationship exist between the presentation of the dysphagia and the participants’ 
CD4 count, age and HAART regimen?  
1.2.4. Did the results of the Mann Assessment of Swallowing Ability (MASA) (Mann, 
2002) significantly correlate with the results of the Modified Barium Swallow 
(MBS)?
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2. LITERATURE REVIEW 
2.1. Overview of HIV/AIDS  
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) 
have had far reaching consequences for both the scientific and medical sectors throughout the 
world. HIV was discovered in the USA in 1981 when a rare combination of diseases was co-
occurring in numerous patients. Only in 1983 was it discovered that a virus was causing these 
diseases and in 1986 the scientists termed it the Human Immunodeficiency Virus (Van Dyk, 
2008). There is evidence that is now supporting the idea that HIV originated in Africa 
(UNAIDS, 2003). Experts in the field of HIV suggest that in the 1960’s approximately 2 000 
people in Africa were infected with the virus (UNAIDS, 2003). The first epidemic is believed 
to have occurred in Kinshasa in the 1970’s as there was a sudden increase in the number of 
patients with cryptococcal meningitis, Kaposi’s sarcoma and pneumonia (UNAIDS, 2003). 
Due to labour migration that occurred throughout Africa in the 1980’s the spread of HIV was 
steadily reaching epidemic proportions. However, it is thought that the first case of HIV in 
South Africa was a white homosexual air steward from the United States of America in 1982. 
Initially, in South Africa, HIV was restricted to the white homosexual population in the 
1980’s but this rapidly started to change during the early 1990’s as HIV/AIDS was beginning 
to be seen in rural African populations (UNAIDS, 2003).  
 
2.2. Burden of the disease 
HIV/AIDS has become the world’s most serious public health problem (UNAIDS, 2009). 
Since the start of the epidemic, almost 60 million people have become infected with 
HIV/AIDS and 25 million people have died from HIV related illnesses in Africa (UNAIDS, 
2009). Over the past few years, there has been an alarming increase in the amount of 
HIV/AIDS patients recorded in Africa (Besige, et.al, 2007). This disease has orphaned over 
14 million children worldwide (UNAIDS, 2009). Sub-Saharan Africa is the region from 
where most of the HIV infected population originates, which is 67% of the HIV population, 
estimated to be 22.4 million people (UNAIDS, 2009). Within Sub-Saharan Africa, these 
HIV/AIDS epidemics vary greatly from country to country. However, in South Africa the 
levels of people being infected with HIV/AIDS is increasing and varies within each province 
with Kwa-Zulu Natal being the province with the majority of HIV infected individuals 
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(UNAIDS, 2009). The majority of the world’s HIV population is found in South Africa 
which is approximately 5.7 million people (UNAIDS, 2009). In terms of gender, Statistics 
South Africa (2010) showed that 19,7% of the adults who are living with HIV/AIDS were 
female and therefore 80.3% were male. In regard to age, Statistics South Africa (2010) 
revealed that the largest age group of people who were infected with HIV/AIDS were 
between 15 and 49 years of age. UNAID (2010) stated that the prevalence of the virus in 
women is between the ages of 25 -29 whereas for men it is between the ages of 30 to 44. 
These statistics show that the virus is affecting adults who are in their child rearing years and 
who are of  working age.  
 
Due to the large number of individuals with HIV/AIDS, this epidemic can affect a country in 
numerous ways. Most people in Africa, who are living with the virus, are in the economically 
productive age group that supports both younger and older generations. However, when these 
individuals develop the symptoms of AIDS they will be the ones who will most likely receive 
little care (Morison, 2001). Bollinger and Stover (1999) state that there are numerous 
economical effects that HIV/AIDS can cause in a household. These will be the loss of income 
of the patients when they are sick, household expenditures may increase and other members 
of the family may miss school or work as a result of assisting their sick family member. The 
social impact is the fact that there will be a large portion of children who will be raised by 
siblings or grandparents. Currently, there are 3.4 million orphans and these children will then 
become an economic and social burden on the country (UNAIDS, 2010). HAART is 
expensive and negatively affects a country’s financial status as the majority of patients who 
are living with HIV/AIDS require HAART as a form of treatment (Conner, Fan & Villarreal, 
2007). Furthermore, the HIV/AIDS individuals also require hospitalisation which is also 
costly for the country’s healthcare sector (Evian, 1992). These factors have a significant 
effect on HIV/AIDS management in the poorer and/or developing countries such as South 
Africa.  
 
2.3. HIV – the virus 
HIV is a retrovirus which has previously been associated with animals and these viruses are 
usually simple in nature (Van Dyk, 2008). However, HIV is in fact a complex virus and this 
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means that the virus can change itself rapidly enough so that different variants of the same 
virus which can be found in the same individual (Van Dyk, 2008). HIV is different from 
other viruses in that it has the ability to invade the immune system of the host (Evian, 1992). 
The virus itself is circular in shape and in the inner core, the virus stores its genetic material 
and proteins (Conner et. al., 2007). The genetic material and the proteins give the virus its 
ability to multiply (Van Dyk, 2008). HIV then attaches itself to a T-lymphocyte (CD4 cell) 
and these cells are the building blocks of the human immune system (Van Dyk, 2008). The 
virus then multiplies once it is inside another cell. The virus can only live inside human cells 
(Van Dyk, 2008). Once the HIV is inside the CD4 cell, it destroys it and this results in the 
decrease in the number of immune cells. The individual becomes infected with outside 
diseases (opportunistic infections) as the body has lost the ability to protect itself (Conner et. 
al, 2007).  
 
2.4. Phases of the disease 
As described above, the HI virus progresses and the CD4 cell count deteriorates. This results 
in a person moving to the stage of the infection termed AIDS (Larson, 1998).  The higher the 
patient’s viral load, the lower their CD4 count is and vice versa (Van Dyk, 2008). The 
progression of the patient developing AIDS is reported to be faster if their viral load is higher 
(Van Dyk, 2008). The clinical illness is usually two to four weeks from the time of HIV 
exposure (Brew, 2007). The illness itself is acute at onset with a median duration of 18 days 
and during this stage, the patient will experience flu-like symptoms (Brew, 2007). In most 
patients, there is a rapid resolution of these symptoms that is followed by a period of 
asymptomatic infection that can last for years (Brew, 2007). Patients that present with 
symptoms of HIV, especially for a period of longer than two months, reportedly progress to 
AIDS more rapidly (Brew, 2007).   
 
There are different stages during the progression of the disease and these stages are 
categorised according to a person’s CD4 count (Larson, 1998). The first stage is the Primary 
HIV Infection stage and this is when the patient changes from being HIV negative to HIV 
positive (seroconversion) (Shoub, 1999). Literature says that 60% of patients in this stage 
will present with symptoms similar to that of glandular fever e.g. sore throat, nausea, 
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vomiting, muscle pain, swelling of lymph nodes and gastrointestinal symptoms (Van Dyk, 
2008). Symptoms at this stage will also include: wasting syndrome (unexplained weight loss), 
lymphadenopathy (swelling of the lymph glands) and neurological diseases which result in 
dementia, spinal cord damage and peripheral nerve damage (Conner, et. al., 2007). The 
second stage of the disease is termed the Asymptomatic Latent Stage and this is when the 
person has a CD4 cell count of between 500 and 800 cells/mm3 of blood and presents with 
symptoms such as: swelling of lymph nodes, fever, herpes zoster, rashes, oral lesions, 
respiratory infections and fatigue (Evian, 1992). The third stage of the HIV infection is 
termed the Minor Symptomatic Stage and this is when the patient has a CD4 count of 
between 350 and 200 cells/mm3 (Brew, 2007). During this stage the individual may 
experience the following symptoms: candida, recurrent herpes infections, night sweats, 
diarrhoea, abdominal discomfort and hairy leukoplakia, persistent coughs, lymphadenopathy 
and bacterial skin infections (Van Dyk, 2008). The fourth and final stage is termed the Severe 
Symptomatic Stage (AIDS- defining stage) which is when a person has a CD4 count of less 
than 200 cells/mm3. During this stage, a patient is emaciated, with recurrent candida, herpes 
zoster as well as infections of the mouth, throat and oesophagus (Van Dyk, 2008). This 
means that the patient may have complications in their ability to swallow. Other symptoms 
during this stage include: diarrhoea, nausea, vomiting, pneumonia, peripheral neuropathies, 
HIV encephalopathy and gastrointestinal tract infections (Conner, et. al, 2007).  
 
2.5. Transmission of HIV 
A person acquires HIV/AIDS through bodily fluids such as blood and sexual fluids (Larson, 
1998). An individual can contract HIV via contact with blood such as in needle sharing/blood 
transfusions and mother to child transmission through childbirth (Brew, 2007). A person can 
also contract HIV through sexual fluids (semen and vaginal fluids) when having unprotected 
sexual intercourse (Evian, 1992). In South Africa, the most common form of transmission is 
via sexual intercourse followed by mother to child transmission (UNAIDS, 2009). The least 
reported form of transmission in South Africa is that of needle sharing and blood transfusions 
(UNAIDS, 2009).  
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2.6. HIV testing  
In South Africa, the majority of HIV antibody tests are done by testing a patient’s blood 
(Conner, et. al., 2007). An antigen test can be done which is called the HIV PCR RNA test. 
This test looks at the number of viral RNA particles available in every ml of blood (viral 
load) (Van Dyk, 2008). However, it is very expensive and needs to be analysed in a 
laboratory. These tests only show a positive result 10-14 days after the individual became 
infected (Brew, 2007). The cheapest and most commonly used test is the ELISA test. This 
test is considered rapid and does not require laboratory analysis (Conner, et. al., 2007). A 
patient will have a positive result if the virus is detected within the blood sample (Brew, 
2007). However, it is important to note that in some individuals it may take 6-12 months after 
their initial HIV exposure for their test results to be positive (Van Dyk, 2008). An 
acknowledged limitation of the test is that there can be false positives. However, in South 
Africa, two positive ELISA test results are considered adequate evidence of the HIV infection 
(Van Dyk, 2008).  
 
2.7. HAART  
People who are infected with HIV/AIDS are treated with Highly Active Antiretroviral 
Therapy (HAART) (Larson, 1998). HAART is a powerful, life-saving drug that is not a cure 
for HIV but that can slow down the progression of the disease and add many years to the 
lives of those who take them (Cohen, 1999). HAART has four primary goals:  
1. To reduce the viral load as much as possible  
2. To restore and/or preserve the immunological function as much as possible  
3. To improve the patient’s quality of life and  
4. To reduce HIV-related illnesses and death (Van Dyk, 2008).  
HAART works by inhibiting the HI virus activity in the cell at various points. These points 
include the attachment of the HI virus to the human, the replication of the RNA and the 
maturation of the HI virus within the cell (Conner, et al. 2007). HAART therefore works 
because it  blocks the process of converting the cells RNA to DNA (Cohen, 1999). HAART 
also blocks a protein which prevents the virus from getting out of the cell causing it to die 
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(Cohen, 1999). HAART comprises of three or four different types of medications which 
include NRTIs, NNRTIs and PIs. NRTIs (Nucleoside/ Nucleotide Reverse transcriptase 
inhibitors) and NNRTIs (Non - Nucleotide Reverse transcriptase inhibitors) work to inhibit 
the HI virus from replicating its’ RNA. Protease inhibitors interfere with the formation of 
new viruses by ‘paralysing’ the protease enzyme and therefore preventing the virus from 
replicating itself (Brew, 2007).  Fusion inhibitors prevent the HI virus from entering the host 
cell (Van Dyk, 2008).  
 
 In South Africa, HAART became freely available to the public health sector in April 2004 
(National Antiretrovial Treatment Guidelines, 2004). Fusion inhibitors are currently not 
available in South Africa.   
 
There are three different HAART regimens which are used in South Africa. These regimens 
represent the combination of the different drugs that are used in each regimen (National 
Antiretrovial Treatment Guidelines, 2004).  
 
Table 1: HAART regimens used in South Africa  
Regime  Drug Category Indication 
1 a  D4T 
3TC 
EFV 
NRTI and NRTI and 
NNRTI 
For men and women 
who are not in child 
bearing ages and who 
are using injection 
contraception  
1 b  D4T  
3TC 
NVP 
NRTI 
NRTI 
NNRTI 
Women who cannot 
guarantee reliable 
contraception  
2 AZT 
Ddl 
NRTI 
NRTI 
For patients who are 
virologically failing 
regime 1 despite 
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Regime  Drug Category Indication 
Lopinavir/ ritonavir  PI showing their 
adherence to the 
regime.  
(National Antiretroviral Treatment Guidelines, 2004). 
 
There are various side effects of the HAART which are mentioned in the table below (Van 
Dyk, 2008). These side effects can lead to a decrease in the individual’s quality of life as well 
as poor adherence to the medication (Daly, 2004).  
 
Table 2: HAART medication and side effects  
Medication name  Class of drug  Side effect  
AZT NRTI Gastro – intestinal (GI) upset, 
headache, myopathy 
Videx  NRTI Peripheral neuropathy, nausea, 
diarrhea,  
Hivid  NRTI Peripheral neuropathy, oral 
ulcers,  
Epivir NRTI GI upset, anaemia 
 D4T  NRTI Peripheral neuropathy,  
Abacavir NRTI GI upset 
Combivir (AZT & 
lamivudine) 
`NRTI Myopathy, nausea, vomiting,  
Tenofovir NtRTI Headache, GI upset,  
Nevirapine NNRTI Rash and hepatitis  
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Medication name  Class of drug  Side effect  
EFV NNRTI Rash, CNS symptoms  
Nelfinavir PI Diarrhea  
Indinavir PI GI disturbances, headache  
Ritonavir PI GI upset, diarrhea, taste 
perversion  
Fortovase  PI GI upset, headache  
(Van Dyk, 2008) 
 
Side effects such as GI upsets, taste perversions as well nausea and vomiting may lead to a 
person not wanting to or having an inability to eat (Daly, 2004). It is therefore important for 
the SLP to assess the causes of the dysphagia as to determine whether the patient was on 
HAART at the time of the assessment.  
 
2.8. Normal swallow physiology  
Swallowing is an extremely complex process that requires the involvement of the central 
nervous system to co-ordinate it. The co-ordination centre responsible for the process of 
swallowing is located in the reticular formation in the medulla which is located in the 
brainstem (Bass, 1997). The involvement of the central nervous system (CNS) would indicate 
that swallowing encompasses both voluntary and involuntary movements that rely upon both 
sensory and motor input from cranial nerves. Swallowing is a complex process that utilizes 
31 pairs of striated muscles (Bass, 2006).  
 
The act of swallowing or deglutition is a continuous process (Langley, 1993). The act of 
swallowing is better understood if it is considered as one continuous process with four 
components or stages. These stages act together in an integrated manner to achieve a 
successful swallow function. By dividing the swallow into four stages, it makes the process 
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easier to identify where the dysphagia is occurring and how to assess and manage it. 
(Langley, 1993). Each of these stages is interdependent and must be carefully assessed to 
fully understand dysphagia (swallowing disorder). The four stages of swallowing are the oral 
preparatory phase, the oral phase, the pharyngeal phase and the oesophageal phase (Cichero, 
2006). Respiration is also important in the swallowing process. In the oral phase the patient 
breathes through their nose. As the pharyngeal phase begins, breathing is ceased for 
approximately one second. Breathing is then commenced again during the oesophageal 
phase. If a patient has difficulty with respiration or the co-ordination of the respiration during 
the swallow, then that can also lead to a dysphagia (Cichero, 2006).    
 
The first stage of the swallowing process is the oral preparatory phase (Langley, 1993). The 
oral preparatory phase involves lip closure, buccal and facial musculature tension, 
mandibular (jaw) movement, lingual range of motion (ROM) and anterior velar movement. 
During this stage food is transferred from the oral cavity to the oropharynx (Bass, 2006). The 
movements that occur in the oral preparatory phase will be dependent on the consistency of 
what is being swallowed (Cichero, 2006). During this phase, the food is mixed (chewed) and 
manipulated with saliva to form a bolus (Logemann, 1998).  
 
Chewing is a voluntary process which is stimulated by placing food between the molars and 
the sensory information is picked up by the teeth and gums (Cichero, 2006). The masseter, 
medial pterygroids and temporalis muscles are involved with mastication (Bass, 2006). For 
chewing or mastication to occur, the jaw needs to actively engage by opening and closing. 
This involves the digastric and lateral pterygroids muscles which allow the mandible to open 
and close (Langley, 1993). Secondly, the shaping of the bolus must occur. The tongue moves 
around the oral cavity, pressing the bolus against the hard palate and the ridge of the teeth. 
The buccinator muscle is involved in keeping the lips closed so that the food remains in the 
mouth (Logemann, 1983). The soft palate is lowered during this stage and nasal breathing 
occurs (Langley, 1993). 
 
The next phase of the swallow is the oral phase. This phase begins as the bolus is prepared to 
be moved posteriorly towards the pharynx (Logemann, 1998). The tip and blades of the 
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tongue then rise and form a chute and funnels the bolus to the pharynx (Langley, 1993). 
When the bolus reaches the faucial arches the swallowing reflex is initiated. The soft palate 
rises and breathing ceases for approximately one second (Langley, 1993). The oral phase 
needs adequate lip closure to prevent anterior spillage, adequate lingual movement and intact 
buccal musculature to prevent pooling (Cichero, 2006). When the food enters the pharynx, 
the pharyngeal phase begins.  
 
The pharyngeal phase begins when the swallow reflex is initiated. This phase involves the 
highly co-ordinated transport of material from the oropharynx, around the occluded laryngeal 
vestibule and into the relaxed oesophagus (Bass, 2006). This stage is involuntary (Langley, 
1993). During this stage, breathing has ceased. The bolus is thrust down as the faucial arches 
constrict, the soft palate elevates and the pharyngeal constrictors contract. The bolus is then 
moved into the valleculae as the pharyngeal muscles constrict, the base of the tongue moves 
forward, the larynx elevates, the vocal cords adduct and the epiglottis folds down over the 
opening of the larynx (Langley, 1993). The bolus is then moved through the final part of the 
pharynx and into the cricopharyngeal sphincter and enters the oesophagus via peristalsis. 
Peristalsis is described by Schulze-Delirieu & Perlman (1998) as a co-ordinated propulsive 
contraction of the oesophagus which helps propel the bolus through the oesophagus into the 
stomach. The pharyngeal phase should usually last approximately one second (Logemann, 
1997).  
 
Finally, the bolus enters into the involuntary oesophageal phase. This stage is when the 
material is transported along the oesophagus into the gastro-oesophageal sphincter (Bass, 
2006). The food moves down the oesophagus through peristalsis (Logemann, 1983). The 
bolus then enters the stomach via the gastro-oesophageal sphincter (Langley, 1993). 
 
In summary, normal deglutition is a continuous process that is rapid and involves both 
voluntary and involuntary aspects that require complex neuromuscular control (Logemann, 
1997). This control involves the interplay of numerous sensory and/or motor cranial nerves as 
well as specific parts of the brain that are supplying information to the appropriate muscles of 
deglutition (Bass, 2006). The process of swallowing basically involves the transfer of food 
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from the mouth to the stomach where it can be digested. If there is an abnormality in any part 
of this process, it is termed a dysphagia.  
 
Dysphagia can occur as result of numerous medical complications which can affect the CNS 
or the anatomy of the swallowing mechanism. How can a CNS complication result in a 
dysphagia? A study done by Hoshino & Kobayashi (1994) highlighted that stroke is a leading 
cause of dysphagia and aspiration pneumonia in adults. Langley (1993) and Logemann 
(1997) state that swallowing disorders occur in patients with numerous neuromuscular effects 
such as: stroke, head injuries, cranial nerve palsies, myopathies and degenerative diseases. As 
the CNS serves as a reservoir for the HI virus, this can result in neurological complications, 
thereby causing a possible dysphagia (Brew, 2007). It is therefore important for a study to be 
conducted in this area especially in South Africa where there is an epidemic of HIV disease.  
 
2.9. How HIV can lead to dysphagia 
HIV destroys the immune system of its host and eventually leads to AIDS. It also provokes a 
variety of problems, one of which is dysphagia. Dysphagia in adults who are infected with 
HIV/AIDS can be triggered by the effects of the virus, opportunistic infections and HAART.  
 
2.9.1. HIV  
The HI virus is able to affect the CNS which comprises of the brain and spinal cord (Brew, 
2007). Cohen & Burger (2007) highlighted the fact that the brain was the second most 
common organ to be affected by the HI virus, second only to the lungs. Mochan, Modi & 
Modi (2002) stated that up to 40% of HIV positive patients will have some form of 
neurological manifestation. The virus is able to cross the blood brain barrier and can therefore 
lead to changes in white matter of the brain and can affect the functioning of the cranial 
nerves and blood vessels (Brew, 2007). If the cortex (posterior cortex and brainstem) is 
affected it will affect the overall swallowing physiology especially on muscle functioning 
such as in the case of meningitis, dementia or stroke (Logemann, 1997). In the case of a 
stroke, the exact role of how the HI virus can cause a stroke is not yet known. It is suggested 
that due to vasculopathies of the extra and intracranial arteries the virus can cause a stroke 
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may perhaps occur (Bryer, Candy, De Villiers, Tipping & Wainwright, 2007). The 
vasculopathies are also true in the cases of dementia (Bryer, et. al, 2007). As the HI virus 
affects the dorsal root ganglions and causes degeneration of the distal axons of the nerves, a 
neuropathy can arise (Cherry, Hoke, Keswani, McArthur & Pardo, 2002). HIV related 
neuropathies are the most common neurological manifestation in the HIV population (Cherry, 
et. al, 2002). These neuropathies can lead to a dysphagia as both the oral and pharyngeal 
phases require optimal functioning of the cranial nerves. The most commonly affected cranial 
nerves have found to be the sixth nerve followed by the third, fourth, seventh, eighth, tenth, 
eleventh and twelfth (Cohen & Berger, 2007). The HI virus can also result in myopathies 
which affect the musculature that is required at all the stages of the swallow (Cherry, et. al, 
2002). Therefore, it can be assumed that in a patient who has a myopathy, it is possible that 
the patient has an oropharyngeal dysphagia. It can therefore also be assumed that as the CNS 
holds and is affected negatively by the HI virus in that it can lead to a dysphagia (Brew, 
2007). As the virus effects the functioning of the CNS, this can lead to various oral and 
pharyngeal phase disorders. The medical consequences of the CNS related dysphagia can be 
a poor cough reflex, poor sensation and therefore possible aspiration.   
 
2.9.2. Opportunistic infections 
The CNS can also be affected due to various opportunistic infections (Bryer, et. al, 2007). As 
the viral load begins to increase, the patient becomes more vulnerable to opportunistic 
infections (Katz, 2003). Studies that have been conducted in the area of HIV/AIDS have 
discovered other opportunistic infections that can result in a dysphagia as these infections 
affect the anatomy of the swallowing mechanism. Bhojwani and Prasad (2006) showed that 
49% of patients who were living with HIV/AIDS complained of oropharyngeal symptoms 
and up to 70% of those patients developed oropharyngeal symptoms during the course of the 
disease. The opportunistic infections can be categorised into bacterial, fungal, viral and 
malignant (Brew, 2007). Some bacterial infections include: meningitis, herpes simplex and 
toxoplasmosis. The most common bacterial infection found in patients who are living with 
HIV/AIDS is reported to be bacterial meningitis (Cohen & Berger, 2007). Bacterial infections 
have also been known to cause various neuropathies which will affect the functioning of the 
cranial nerves (Cohen & Berger, 2007). As these infections can lead to poor functioning of 
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the cortex and cranial nerves, it can be inferred that a patient who has a bacterial infection 
which affects the CNS, may present with a dysphagia. 
 
2.9.2.1. Fungal infections 
The most common fungal infection that can occur in a patient who is living with HIV/AIDS 
is candida (Anteyi et. al, 2003).  The most common oral manifestation found in numerous 
studies done in both developed and developing countries was oral candida (Besige, et. al, 
2003; Bhojwani & Prasad, 2006; Gillespie, 1993). These studies also assert that if a patient 
presents with oral candida that the patient is predisposed to developing oesophageal as well 
as possible laryngeal candida (Bhojwani & Prasad, 2006). Candida has been proven to lead to 
dysphagia and odynophagia (painful swallow). However, the specific presentation of the 
dysphagia in terms of the actual symptomology has not been widely investigated. Candida 
can occur in the oral cavity as well as in the larynx and oesophagus (Cohen & Berger, 2007).  
 
2.9.2.2. Viral infections 
The numerous viral infections that can occur in a patient living with HIV/AIDS are: 
meningitis, Guillen-Barre syndrome, cytomegalovirus as well as viruses that can lead to 
encephalopathies and myopathies (Brew, 2007). Myopathies and Guillen-Barre syndrome 
result in muscle pains and weakness (Berger &Cohen, 2007). In order for a normal swallow 
to occur, it is imperative that the muscles of the head, neck and spinal cord are functioning 
optimally, therefore a patient who is suffering from a CNS related disorder, may suffer from 
dysphagia. Cytomegalovirus can result in encephalitis and therefore suppress the functioning 
of the CNS which can lead to a dysphagia (Brew, 2007). CMV can also lead to complications 
within the oesophagus resulting in a possible mechanical cause of dysphagia (Cohen & 
Berger, 2007).  
 
2.9.2.3. Malignancies  
In some cases, opportunistic infections can become malignant such as in the case of Kaposi 
sarcoma and squamous cell carcinoma (Besige, et. al, 2003). Kaposi sarcoma can lead to 
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large painful oral lesions which may result in poor oral movement and therefore a dysphagia 
(Anteyi, 2003). In the case of squamous cell carcinoma, it usually manifests in the larynx and 
oesophagus (Cohen & Berger, 2007). For malignancies, the treatment is usually radiation or 
chemotherapy (Katz, 2003). Side effects of these treatments can lead to a dry mouth as well 
as pain as the oral mucosa which becomes dry and exposed (Gillespie, et. al, 1993).  
 
2.9.3. HAART 
HAART, a treatment regimen that patients with HIV/AIDS have to take, has been known to 
have side effects that can lead to possible dysphagia (Daly, 2004). Some of these side effects 
include: nausea, vomiting, GI upsets, gastro-oesophageal reflux disease (GORD) and taste 
aversions (Van Dyk, 2008). HAART can also result in neurotoxicity and cause a neuropathy, 
specifically in the cases of NRTI and d4T (Cherry, et. al, 2002). If a patient is feeling ill due 
to these side effects, it will prevent the patient from eating adequately which can lead to 
malnutrition and dehydration (Daly, 2004). These side effects can also affect a person’s 
quality of life negatively because if a patient feels unwell it will affect their health, 
psychological and social well being (Daly, 2004).  Some of the side effects of HAART can be 
nausea and vomiting. These are serious side effects as they can lead to dehydration and 
malnourishment. It is important to manage this in an HIV/AIDS patient as good nutrition is 
vital in order to maintain an adequate immune system thereby preventing opportunistic 
infections (Antoni, Costa, Dahn, Gonzalez, Malow, Penedo & Schneiderman, 2003).  
In summary, the stages of swallowing can be affected in the following ways: 
• Oral candida: oral candida is a fungal infection that occurs in the oral mucosa, mostly 
on the tongue and can be very painful (Anteyi, et al, 2003)  
• Kaposi Sarcoma: this is a form of cancer that is common in HIV positive patients. 
These cancers can occur in the oral cavity therefore restricting oral musculature 
movement and creating a blockage so that the bolus is unable to move from the oral 
cavity to the pharynx (Besige, et al, 2007).  
• Neurological conditions such as stroke, meningitis, AIDS dementia complex, 
myelopathy and cerebellar disorders: as stated above, up to 70% of patient who are 
living with HIV/AIDS will experience some form of neurological deficit. These 
neurological impairments can lead to decreased sensation in the oral cavity as well as 
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decreased strength and movement of the oral musculature which can result in 
difficulty manipulating the bolus (Bass, 2006).  
• Steven Johnson Syndrome: this disease results in the epidermis being removed and 
subsequent pain and bleeding all over the body including the oral cavity (Clayton & 
Kennedy, 2007).  
 
How the pharyngeal phase is affected by various infections: 
In summary, the pharyngeal phase of the swallow involves the bolus passing from the oral 
cavity and into the pharynx before it reaches the oesophagus. Breathing is ceased during this 
phase. HIV/AIDS can affect the pharyngeal stage in the following ways through 
opportunistic infections: 
• Candida: the fungal infection can spread down into the pharynx which can result in 
pain and discomfort during the swallow (Anteyi, et. al., 2003).  
• Neurological conditions: some neurological conditions can result in weakness, 
delayed and inco-ordinated swallow which can lead to aspiration (Brew, 2007).  
 
How the oesophageal phase is affected by various infections:  
The oesophageal phase of the swallow begins when the bolus passes through the UES until 
the bolus enters the stomach. This can be affected by candida which will result in 
odynophagia (Anteyi, et. al., 2003). 
 
2.10. Concerns about dysphagia in HIV 
Aspiration pneumonia is a common medical consequence of dysphagia and has the most 
severe side effects on the individual (Ellis, Miford, Morton & Pinnington, 2002). Aspiration 
pneumonia is caused by aspirating on ingested material. Aspiration is when secretions or 
ingesta enter below the level of the true vocal cords (Perlamn & Schule-Delirieu, 1998). 
Therefore, aspiration pneumonia can interfere with breathing or cause pulmonary 
inflammation or infection and in severe cases, even death (Cichero, 2006). Aspiration can 
occur before the swallow or during the pharyngeal phase and is more likely to occur during 
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the pharyngeal phase in patients with a neurodisability due to pharyngeal delay and poor 
laryngeal elevation (Ellis, et. al, 2002; Curtis & Langmore, 1997). Furthermore, poor 
laryngeal elevation can lead to impaired laryngeal inlet closure and patients can therefore 
aspirate during the swallow (Ellis, et. al, 2002). In chronic cases of dysphagia, it can lead to 
pneumonia, which is a lung infection (Cichero, 2006). Perlman and Schulze-Delirieu (1998) 
describe aspiration pneumonia as an infection of the lung following aspiration. Pneumonia is 
important to manage and prevent because complications of pneumonia can be asthma attacks, 
chronic coughing, lung abscesses or even death (Brockett, 2007).  Ellis et. al. (2002) reported 
that patients who aspirate suffer from more frequent chest infections than those who do not 
aspirate. A patient can aspirate either before, during or after the pharyngeal phase (Cichero, 
2006). A patient can aspirate before the pharyngeal phase begins as the food spills over the 
tongue before the swallow is initiated. Aspiration can also occur during the pharyngeal phase 
when the food enters the trachea. Lastly, aspiration can occur after the swallow when the 
patient aspirates on their reflux (Cichero, 2006). Based on the above, all the possible risks 
and complications of aspiration have been highlighted and it is therefore one of the key areas 
that a speech therapist needs to assess and manage appropriately. 
 
Patients who do not display a cough reflex are also at risk of developing aspiration 
pneumonia. It can occur as the patient will not be able to ‘cough up’ the bolus that is in the 
airway (Halvorsen, et. al, 2003). As HIV/AIDS affects the central nervous system, this can 
result in the decreased functioning of the nerves and musculature that are involved in the 
swallow.  This decreased functioning or neurodisability presents as weakness, inco-
ordination, paralysis and decreased sensation of the pharyngeal and laryngeal musculature 
and this can lead to weak or absent cough reflex, followed by aspiration. Patients who have a 
decreased level of consciousness will be at risk of aspiration as the patient is often unaware of 
the food in their mouth. They will therefore be unable to control the bolus and thus initiate 
the swallow reflex adequately (Miller & Schultze-Delirieu, 1997). In addition, patients who 
have a CNS infection (such as dementia or meningitis) may have a decreased level of 
consciousness. This can also cause aspiration (Cichero, 2006). Patients can aspirate on their 
own oral bacteria which will also lead to pneumonia as the bacteria from the saliva that enters 
the lungs will create an infection (Scannapieco, 1999). Odynophagia (painful swallow) can 
occur possibly as a result of various opportunistic infections which may lead to difficulty 
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swallowing. In summary, a patient who presents with a neurodisability is at increased risk of 
developing a dysphagia and that can lead to possible aspiration.  
Other medical consequences of dysphagia include anaemia, weight loss and dehydration 
(Stevens, 2005). A person is considered to be anaemic when there is insufficient iron in their 
blood. The HI virus can result in an individual developing anaemia as the virus causes 
various haematological complications which prevent the iron from remaining in the body as 
well as through various opportunistic infections (Moyle, 2002). Anaemia in the patient who is 
living with HIV/AIDS can have serious medical side effects as anaemia can lead to increased 
mortality, especially in patients in the advanced stages of the disease (Munderi, Ssali, & Reid, 
2006).  Anaemia can also lead to a decrease in a patient’s quality of life because it results in 
fatigue (Moyle, 2002). HAART has been shown to prevent the progression of anaemia except 
in the case of d4T which can result in anaemia developing (Moyle, 2002). However, if a 
patient is dysphagic as well, it can exacerbate the problem.  If a patient is either eating food 
or drinking liquids that do not contain vital nutrients due to the dysphagia, this can also lead 
to anaemia. This is of the utmost importance in the HIV population because adequate 
nutrition is vital in maintaining a good immune system (Hussey, Kossew, Maartens & Visser, 
2003). Adequate intake of vitamins and minerals will assist the immune system with 
producing anti-bodies (T-lymphocytes) which will strengthen the immune system (Hussey, 
et. al, 2003). In HIV/AIDS patients, the number of T-lymphocytes are decreased which 
results in the immune system not functioning optimally. It is therefore, of vital importance 
that the patient receives adequate nutrition in order to assist in maintaining a strong immune 
system (Cohan, Gregg, Murreheim, Rudenstein & Turner, 1993).This is crucial because 
having an infection will decrease a patient’s nutritional status and having a decrease in 
proteins and micronutrients will lead to a decrease in antibody formations. Illness decreases 
the appetite and therefore the patient will not want to eat (Scrimshaw, 2007). Cohan, et al, 
(1993) reported that a patients’ nutritional status influences survival independent of the 
patients’ CD4 count. Scrimshaw (2007) highlights that in patients with HIV/AIDS, as the 
disease progresses rapidly, that this progression will lead to vitamin deficiencies also due to 
patients not eating regularly.  
 
The majority of HIV patients suffer from weight loss and malnutrition as a side effect of the 
disease (Klotz, Ngo, Nguyen, Nguyen & Vu, 2007). The HI virus may result in weight loss 
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because of increased energy usage, due to the response to opportunistic infections (Parker, 
Waters & Williams, 1999). Profound weight loss in the HIV population is associated with 
rapid disease progression and increased mortality (Parker, et al. 1999). It is mentioned that 
weight loss in patients who are living with HIV/AIDS is multifactoral and that early 
identification and management is essential as it can promote survival and improvement in 
daily functioning (Parker et. al, 1999). Apart from the HI virus itself, during the time of an 
active infection, nutrition levels may decrease due to poor food intake (Hussey et. al, 2003). 
Various gastrointestinal complications have been associated with weight loss such as: oral 
and oesophageal candida, xerostomia and Kaposi sarcoma (Parker, et. al. 1999). These 
opportunistic infections have also been associated with a dysphagia (Besige, et. al, 2003). 
Patients who are suffering from tuberculosis (which is common in HIV/AIDS) may 
experience a decrease in appetite (Brew, 2007). In addition, a dysphagia can lead to 
malnutrition and weight loss because the patient is unable to eat a wide variety of foods or 
any food at all (Anteyi, et. al., 2003). However, HAART has been associated with a reduced 
prevalence in weight loss (Parker, et. al, 1999).  
 
Dehydration can also occur as a side effect of dysphagia either because the patient refuses to 
drink liquids or because the patient is unable to tolerate liquids and thin liquids have been 
removed from their diet in order to prevent aspiration (Langley, 1993). It is important to 
manage the patient correctly as dehydration can lead to kidney failure and ultimately death 
(Brew, 2007).  
 
It is therefore of great importance that a dysphagia in the HIV/AIDS population is managed 
correctly in order to avoid some or all of the above-mentioned consequences, as these can 
have significant implications on the patient’s quality of life and health. Ellis et. al. (2002) 
states that therapists and other clinical professionals need to manage these feeding difficulties 
effectively, hence the importance of this study. 
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2.11. Multidisciplinary Team management of dysphagia      
In order to assess and manage a patient correctly numerous team members are required to be 
involved (Langley, 1993). The assessment requires the speech therapist to screen and conduct 
a full bedside assessment. Once it has been established that a dysphagia is present it may be 
necessary to conduct further radiological examinations. Ear, nose and throat (ENT) doctors as 
well as radiologists are often called to conduct assessments such as Fiberoptic Endoscopic 
Evaluation of Swallowing (FEES) and modified barium swallows (Dziewas, Hamacher & 
Oelenberg, 2009). Once a thorough assessment has been conducted and a diagnosis has been 
made, it is important to develop a treatment plan. As the swallowing mechanism consists of 
numerous nerves and muscles it is important to note that the management of the HIV/AIDS 
dysphagic patient requires numerous medical professionals to be involved. Langley (1993) 
states that the following medical professionals need to be involved in the care of these 
patients: Medial staff (neurologists, ENT, etc), nurses, dieticians, physiotherapists, 
occupational therapists, radiographers/ radiologists. The neurologists and ENT surgeons are 
involved for the medical and surgical treatment of the neurological and structural cause of the 
dysphagia (Langley, 1993). Nurses are responsible for the monitoring of patient’s vital signs 
before, during and after the swallow as well as oral care which is important to prevent 
infections (Kalra, Ramsey & Smithard, 2006). Dieticians are essential in deciding what types 
of food the patient can eat as well as monitoring the patient’s nutritional status (Langley, 
1993). Occupational therapists are important to establish independence during activities of 
daily living, such as eating (Langley, 1993). If a patient is able to eat independently it can 
improve their confidence and therefore their quality of life (Druck & Ross, 2002). 
Physiotherapists are experts in the area of muscle physiology and function and can therefore 
assess and treat the muscles involved in the swallowing mechanism (Langley, 1993). The 
principal team member in managing the dysphagic patient is the speech therapist as the SLP 
has specialised training in the head and neck anatomy and physiology and is the only member 
who can perform swallowing assessments, differential diagnosis and the appropriate 
management of the dysphagia (Pettigrew & O’ Toole, 2007).  
 
2.12. Assessment of dysphagia         
As described above, it is important to accurately assess a patient with a dysphagia in order to 
ascertain where the difficulty lies. When assessing a patient, it is important to remember that 
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swallowing can be seen as a hydrodynamic system in which the bolus is transferred through a 
series of in-line chambers that are separated by valves at the entry and exit points (Carrau & 
Simental, 2004). There are different methods for assessing the swallowing mechanism in 
patients. These assessments can be divided into clinical and objective assessments methods.  
 
Initially, the SLP should utilise clinical methods. The SLP will begin by screening the 
patients for a dysphagia. Screenings are important to identify whether an oropharyngeal 
dysphagia is present or not, through reading patient files, asking patients and taking adequate 
histories from the medical professionals (Sheppard in Cichero, 2006).  
 
Once a patient has been screened and found to present with a possible dysphagia, a clinical 
bedside assessment is done. The clinical bedside assessment provides a preliminary 
assessment of the patient’s current medical status, their needs for nutrition and alertness 
(Carrau & Murray, 2006). As the bedside assessment requires the patient to follow 
instructions, not all patients are able to have a full assessment, for example, if the patient has 
a cognitive impairment or is not alert (Carrau & Murray, 2006). When a full assessment is 
applicable, it is usually simple, repeatable and highly sensitive to detecting a dysphagia 
(Hinds & Wiles, 1998). The patient should be seated between 45o and 90o in order to optimise 
safe swallowing (Kalra, Ramsey & Smithard, 2006).  
 
The assessment should begin with a thorough examination of the oral cavity for masses, 
deficits of tongue strength and range of motion, status of the oral mucosa, neurological 
deficits and salivation (Carrau & Simental, 2004). This assessment informs the therapist 
whether there are difficulties in the functioning of the oral musculature that could affect the 
patient’s swallowing ability (Carrau & Murray, 2006). The clinical bedside assessment 
entails the therapist giving different volumes and consistencies of food, assessment of 
dribbling, laryngeal movement, productiveness of a cough, voice changes and the time taken 
to swallow (Broker, 2009). The SLP assesses the swallow using various food consistencies 
ranging from liquid, thick liquid, puree, semi-solid and solid. While the patient is swallowing 
the SLP is evaluating the oral and pharyngeal phases of the swallow (Carrau & Murray, 
2006). During the assessment, the SLP should also evaluate the adequacy of the velopalatine 
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sphincter and pharyngeal contraction (Carrau & Simental, 2004). This is because velopalatine 
sphincter inadequacy can lead to nasal regurgitation in some patients and pharyngeal 
contraction is important in order to prevent pooling of the bolus in the valleculae which can 
lead to later possible aspiration (Bass, 2006). The cranial nerves IX and X should be assessed 
to determine palatal elevation and sensation because if a patient has decreased oral sensation, 
then this can lead to nasal regurgitation and over the top spill. This occurs when the bolus 
flows over the base of the tongue without the patient actively swallowing and this in turn can 
lead to aspiration (Carrau & Simental, 2004). A physical examination of the larynx during the 
swallow may also identify the presence of masses, deep muscle fixation of the tongue base or 
surgical changes that may interfere with the transfer of the bolus in the pharyngeal phase 
(Carrau & Simental, 2004). The advantages of a clinical assessment are that it is quick, 
various consistencies can be used, it does not rely on electricity or technology and it is less 
expensive (Broker, 2009). Due to these advantages, it is convenient to use this assessment 
method in the South African context as there are often budget constraints and lack of 
equipment to assess patients. The bedside assessment also assesses the signs and symptoms 
of dysphagia. The disadvantage of a clinical assessment is that the interpretation of the 
findings is subjective and it is sometimes difficult to accurately assess the pharyngeal phase 
(Langley, 1993). 
 
 For this research, the Mann Assessment of Swallowing Ability (MASA) (Mann, 2002) 
which is a clinical bedside assessment was used. The MASA was developed because there 
was a lack of standardised assessment measures that SLP’s could use for bedside 
assessments. This is important for the SLP community as most patients who present with a 
dysphagia have a poor prognosis and the chance of them developing serious complications 
are high (Mann, 2002). The MASA is a recently developed psychometric swallowing 
assessment that was standardised on hospitalised stroke patients in Australia (Mann, 2002). 
This tool was deemed appropriate to use in the research because it assessed all phases of the 
swallow reflex and has already been standardised, although not on the South African 
population. It has been well documented that HIV is able to cross the blood barrier and enter 
the CNS where it can cause neurologically based problems such as dysphagia. 
The bedside assessment has also been shown to be less sensitive and specific to showing a 
dysphagia (Dziewas, Hamacher & Warnecke, 2009). This subjectivity in the interpretation of 
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the bedside assessment can often require an objective assessment in order to confirm the 
findings of the SLP. This usually occurs when the patient presents with possible pharyngeal 
difficulties. This assessment includes evaluating the swallow from the oropharynx to the level 
of the oesophageal sphincter (Logemann, 1997). There are different methods in which an 
objective assessment can be done, such as Videofluroscopy (VFS) or modified barium 
swallow, Fiberoptic Endoscopic Evaluation (FEES) and cervical auscultation (Burrell et al, 
1998) and oesophograms to name a few (Halvorsen et al, 2003).  
 
FEES is performed by an endoscope being passed through a patient’s nostril allowing the 
pharynx, larynx and oesophageal sphincter to be visualised (Dziewas, et. al. 2009). FEES has 
been proven to be equal to, or better than the MBS in the detection of aspiration and severity 
of residues (Dziewas, et al. 2009). Current research also concludes that dietary and 
behavioural guided management by FEES has proven to have better patient outcomes in 
stroke patients (Dziewas, et. al, 2009). The advantage of FEES is that it can be utilised at the 
patient’s bedside and is repeatable (Dziewas, et. al., 2009). If a patient requires numerous 
evaluations for pre and post rehabilitation assessments, FEES can be used as it is repeatable 
due to the lack of radiation. FEES also allows for the evaluation of the motor and sensory 
components of the swallowing mechanism and permits the assessment of the protection of the 
patient’s airway (Dziewas, et. al, 2009). Studies that have been conducted using FEES as an 
assessment measure on patients with various underlying causes of dysphagia have concluded 
that FEES is a safe method of assessment (Dziewas, et. al. 2009). Various studies that have 
used FEES as an assessment measure have also used a bedside assessment in conjunction 
with the FEES (Dziewas, et al. 2009).  
 
Cervical auscultation is an assessment method where the SLP listens to the sounds of the 
swallow with a stethoscope during the pharyngeal phase in order to detect a dysphagia (Borr, 
Hielsher- Fatabend & Lucking, 2007). The stethoscope is placed on the lateral aspects of the 
neck above the cricoid cartilage in front of the sternocleidomastoid muscle and the large 
blood vessels in the neck (Borr, et. al, 2007). The SLP is required to listen to the sounds of 
the pre, during and post swallow (Coyle, Drinnan, Ford & Leslie, 2007). The advantages of 
cervical auscultation are that it is inexpensive, non-invasive and it can be done with minimal 
co-operation (Coyle, et, al. 2007). The disadvantages are that there is a lack of research 
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proving it’s reliability and validity and relies solely on individual interpretation of the results. 
It should only be used in conjunction with other assessment measures and the SLP requires 
previous experience in interpreting the sounds (Coyle, et. al, 2007). However, there are other 
measures of assessment that are more reliable.  
The Modified Barium Swallow (MBS) is said to be the gold standard in terms of objective 
radiographic assessments (Broker, 2009). Halvorsen (2003) states that MBS increases the 
understanding of the swallow physiology and can identify the dysfunction of the swallowing 
mechanism. The MBS is used to analyse the anatomy and physiology of the oropharyngeal 
swallow and to examine the effectiveness of the selected rehabilitation strategies that are 
designed to eliminate aspiration or excess oral or pharyngeal residue (Logemann, 1997). The 
MBS is also important in order to analyse the entire upper digestive system and it’s periodic 
nature which can lead to missed aspiration, pooling or discrete mucosal masses as well as to 
evaluate the propulsive mechanism velopalatine closure and upper oesophageal sphincter 
closure (Carrau & Simelante, 2004). The MBS is a multidisciplinary evaluation of the 
swallowing mechanism between the radiologist, radiographer and the SLP (Carrau & Murray, 
2006). In the MBS, the patient is seated or standing in an upright posture and ingests a 
barium-coated bolus or has liquid barium of various consistencies which is used at the 
discretion of the SLP (Carrau & Murray, 2006). The radiologist mostly views the images in a 
lateral position from the teeth to the posterior pharyngeal wall (Kalra, et. al, 2006).  The MBS 
usually starts off with thin liquids and then becomes gradually thicker (Carrau & Murray, 
2006). The MBS is of most relevance to this study as the majority of South African 
government hospitals have access to this equipment. This is because the equipment is 
available in South Africa and therefore the costs of running this equipment is kept to a 
minimum.  
 
There are advantages and disadvantages to this assessment method as well. The advantages of 
an instrumental assessment are that it is objective and it is more accurate (Langley, 1993). As 
the swallowing process is rapid, the MBS is capable of capturing the salient components of 
the process over time thereby analysing the physiological components of the swallowing 
mechanism while evaluating the flow of the bolus in relation to the structural movements 
(Logemann, Martin-Harris & McMahon, 2000). The disadvantages of the objective 
assessments are that it is expensive, the patient is exposed to radiation and a limited number 
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of consistencies can be used (Langley, 1993). The SLP must be aware of the signs and 
symptoms of a dysphagia as well as the signs and symptoms of aspiration during the 
assessment. The SLP also requires an adequate knowledge of the anatomy and physiology of 
the swallowing mechanism and how to identify these on an x-ray (Logeman, 1997).  
It is therefore important that an accurate assessment be conducted in order for appropriate 
management of the patient to be done. A study conducted by Atwood, Gross & Ross (2008) 
showed that in 25 patients who were diagnosed with Parkinson’s disease the MBS was shown 
to be highly sensitive in accurately diagnosing swallowing difficulties (Atwood, et. al, 2008). 
The MBS has also been proven to be a powerful tool in the management of the dysphagic 
patient (Logemann, Martin Harris, McMahon, Sandidge & Schleicher, 2000). 
 
There have been some studies that have looked at HIV/AIDS and these studies have been 
summarised below: 
 
Table 3: Research conducted in the area of HIV/AIDS 
Author  Country Sample Measure HAART Findings  
Halvorsen,  
Kearney & 
Moelleken 
USA 17 out 
patients 
Videofluroscopy 
and barium 
esophograms 
Not stated  Dysphagia 
present 
Mangannini, 
Olmos, 
Piskorz & 
Zalar 
Argentina 18 out 
patients  
Videofluroscopy Not known  Aspiration 
noted  
Daly RSA 80 out 
patients  
Questionnaire Not all were 
on HAART 
Dysphagia 
was reported  
 
The above table highlighted that research was being conducted in both developed and 
developing countries. The study that was conducted in South Africa was done by a speech 
therapist but it was carried out utilising a questionnaire. It is noted that these research studies 
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only used objective measures or subjective questionnaires. This research study is different as 
it utilised clinical and objective measures. It is also noted that HAART was not a variable that 
was analysed whereas in this study, HAART was specifically analysed as an independent 
variable. Another significant difference is that these research studies utilized out-patients and 
this study used in-patients. This study therefore took a different methodological approach 
when compared to the other studies that have been conducted in this area.   
The table below is a summary of different articles that highlight what assessment methods are 
being used in dysphagia research in various countries.  
 
Table 4: Current research trends in dysphagia  
Author  Country  Sample Condition  Measure  
Hinds & Wiles  UK 115 CVA Questionnaires 
and the timed 
water swallow 
test  
Brainin, 
Dauchenhausen, 
Enderele, 
Nowotony, 
Teuschel & Trapl  
Austria  50 CVA Gugging 
Swallow Screen 
and FEES 
Roth  Brazil  26 CVA Standard bedside 
swallow 
assessment  
Asimos, Peebles, 
Price, Singh & 
Turner – 
Lawrence 
USA 103 CVA Screening  
Burrel,,. Leder, 
& Sasaki  
USA 400 Neurological, 
medical and 
surgical  
FEES 
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Author  Country  Sample Condition  Measure  
Corti & Martin Argentina   HIV/AIDS Endoscopy  
Corlew &Martin  USA 9 Dysphagia  Videofluroscopy  
Gefter, Laufer, 
Levine, Katzka, 
Pikus, Rubesin & 
Yang.  
USA 381 Dysphagia  Videofluroscopy 
Terre & Merin Spain  64 CVA Clinical bedside 
and 
videofluroscopy  
Alonso, 
Chavarri, Gomez 
Senet & Lucendo 
Villarin.  
Spain  9 Oesophagitis Endoscopy  
Ellis Milford, 
Morton & 
Piunnington 
UK 12 Dysphagia  Videofluroscopy  
Hoshino , 
Kobayahi, 
Okayama, Sasaki 
& Sekizawa  
Japan 30 CVA Clinical (water 
only) 
Kalra, Ramsey & 
Smithard 
UK Not mentioned  CVA Comparison 
between 
videofluroscopy, 
FEES and 
bedside 
 
As is evident from the above table, most studies are being conducted by only one measure, 
either clinical or objective. The majority of the studies have also used a sample size of 
smaller than 100 participants. The studies that have utilised larger populations have used an 
objective method for assessing. Most of these studies have only been conducted in first world 
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countries and none in Africa, therefore showing the need for research to be conducted in this 
area in South Africa. This study therefore utilised both subjective and objective measures 
with a large sample size in order to adequately describe a patient’s dysphagia. The subjective 
assessment that the researcher used was a bedside assessment as this provided the researcher 
with more clinically relevant information in terms of the patient’s signs and symptoms as 
opposed to only a questionnaire. The MBS allowed the researcher to confirm the clinical 
findings.  
 
2.13. Treatment of dysphagia  
After a thorough bedside assessment has been conducted with a possible instrumental 
assessment having been utilised, it is the role of the SLP to treat the swallowing disorder 
(Langley, 1993). There are two methods of treatment that can be used: compensatory or 
rehabilitative (Stevens, 1994). Compensatory techniques are used to compensate for the 
difficulties/symptoms that a patient is experiencing e.g. swallowing manoeuvers and diet 
modifications (Stevens, 1994). Rehabilitative techniques attempt to rehabilitate the 
swallowing anatomy in order for the patient to attempt to swallow normally (Stevens, 1994). 
This study set out to identify the signs and symptoms of dysphagia in HIV/AIDS and that can 
only be established through assessments. Therefore the discussion on treatment is not 
extensive since that is outside the scope of this study. 
 
2.14. Rationale for the study 
For the SLP practicing in South Africa, it is noted that there is little data on how HIV/AIDS 
affects a person’s swallowing ability. Incorrect management of dysphagia can lead to 
increased hospitalisations, aspiration, aspiration pneumonia and ultimately a decreased 
quality of life (Stevens, 1994).Dysphagia can affect quality of life in the following areas 
based upon the International Classification of Functioning, Disability & Health (ICF) model: 
general health, psychological, social and financial well being (Carrau & Murray, 2006). In 
terms of general health, as the patient is unable to swallow, it can increase how the 
progression of the primary disease (HIV/AIDS) occurs (Carrau & Murray, 2006). If a patient 
is unable to eat and becomes malnourished, this can lead to the faster progression of the 
disease i.e. AIDS (Moyle, 2002). Dysphagia can affect a patient psychologically and socially 
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because eating is a social function as well as for nutrition. Due to the dysphagia affecting 
how and what a person may eat this will therefore cause limits in social functions involving 
eating for example eating at a restaurant (Carrau & Murray, 2006). The financial impact of a 
dysphagia can be significant because there are special foods that are required with special 
equipment to prepare the food (e.g. a blender to feed patients through a percutaneous 
endoscopic gastrotomy (Carrau & Murray, 2006). Based on this model, it is therefore of great 
importance that the SLP be involved in the management of dysphagic patients as it has 
serious side effects which can affect a person’s overall quality of life.  
 
As summarised above, the current research is only focusing on one method of assessment 
with smaller sample sizes. This research has utilised both clinical and objective measures in 
order to achieve accurate results. There is also little research being done in this area in South 
Africa. This study is therefore filling a definite void in current research practices. More 
research will yield more valuable information and therefore better patient management and 
quality of life. 
 
This research hypothesised that participants who had a neurological disorder would 
experience more severe signs and symptoms of dysphagia as swallowing is a complex 
neurological process. It was also hypothesized that participants who had a lower CD4 count 
would experience more severe signs and symptoms of dysphagia as their viral load would be 
higher. The researcher also hypothesized that age would not make a significant difference in 
terms of swallowing ability. 
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3. METHODOLOGY 
3.1. Research Aims:  
The primary aim of this research was to describe the swallowing function in a group of adult 
in-patients with HIV/AIDS.  
The specific questions of this research were: 
3.1.1. What were the clinical signs and symptoms of dysphagia in a group of adult in-
patients living with HIV/AIDS?  
3.1.2. Was there a difference between the obtained signs and symptoms of the patients with 
neurological versus opportunistic infections? 
3.1.3. Did a relationship exist between the presentation of the dysphagia and the 
participants’ CD4 count, age and HAART regimen? 
3.1.4. Did the results of the Mann Assessment of Swallowing Ability (MASA) (Mann, 
2002) significantly correlate with the results of the Modified Barium Swallow 
(MBS)? 
 
The null hypothesis was that the swallowing abilities of participants would remain unchanged 
when compared to all of the above variables. The alternative hypothesis was that the 
swallowing abilities of the participants would be affected by one of the above mentioned 
variables.   
 
3.2. Research Design 
This study was a descriptive, cross-sectional, quasi non-experimental design. Descriptive 
designs are aimed at describing a phenomenon (Durrheim et. al, 2006). The study was 
descriptive in nature as it described a particular behaviour, namely, the signs and symptoms 
of dysphagia in patients who are living with HIV/AIDS (Punch, 2005). The advantages of a 
descriptive design are that a lot of information can be acquired through description and it is 
useful in identifying possible variables as well as developing a hypothesis (Punch, 2005). 
This research was a non-experimental design because in these designs there are no 
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comparative groups and a variable will not be manipulated (Punch, 2005). This research 
intended to observe a behaviour, describe the phenomena and establish whether certain 
relationships exist. The advantages of a non-experimental research design are that it is easy to 
implement, cost and time effective and used for descriptive purposes (Punch, 2005). The 
disadvantage of this design is that there is no control group and it therefore does not allow for 
causal inference (Punch, 2005). This study was a cross-sectional design as it describes a 
population at one point in time (Clarke & Cooke, 1998). Cross-sectional studies are 
considered to be a form of observational research (Punch, 2005). As this research is 
describing a phenomenon and patients are being observed, it was therefore appropriate to use 
a cross-sectional design. Cross-sectional research is used to assess the prevalence of acute or 
chronic conditions or to answer questions about the causes of disease or the results of medical 
intervention (Durrheim, et. al, 2006).  
 
3.3. Sample and Sampling Method 
Patients were recruited from a regional public hospital in Gauteng, South Africa. The 
sampling method that was used for this research was non-probability sampling (Durrheim, et. 
al, 2006). The specific type of non-probability sampling method that was used is termed 
convenience sampling as the sample was being drawn from the part of the population that is 
close at hand (Durrheim, et. al, 2006). An advantage of convenience sampling is that it is 
readily available and convenient (Punch, 2005). Non-probability sampling can be further 
divided into accidental or purposive (Punch, 2005). The sampling method that was used in 
the study was purposive because the data was collected with a specific plan in mind within a 
predefined group that needed to be analysed (Durrheim, et. al, 2006). The advantages of 
purposive non-probability sampling methods are that it is economical and convenient. 
However, the disadvantage of this method is that it cannot be ensured that each element of 
the sample can be included (Punch, 2005). Some researchers suggest that non-probability 
sampling may not be entirely representative of the population (Durrheim, et. al, 2006).  
 
A sample of 106 participants was used in the study. The sample for this study was adult in-
patients living with HIV/AIDS at a regional public hospital in Gauteng. These patients were 
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referred to the speech therapy and audiology department from various multidisciplinary team 
members for dysphagia assessments.  
As the sample for this research was very specific, there was a need for exclusion and 
inclusion criteria in order to get appropriate samples (Punch, 2005). The inclusion and 
exclusion criteria were as follows: 
 
3.3.1. Inclusion criteria for the bedside assessment (Mann Assessment of Swallowing 
Ability- MASA) and modified barium swallow: 
• The patients were required to be in-patients: This is because as a therapist in the hospital, 
the ward patients were seen daily. This allowed for accessibility to the sample. As per 
hospital policy, the doctors were required to run a recent CD4 count test, therefore in- 
patients would have had more reliable CD4 counts as opposed to out- patients.  
 
• The patients needed to be over 18 years of age. The reason for this requirement was 
because this study focused on adults. In addition, the regional hospital only caters for 
adults as well.  
 
• The patient must have been diagnosed as having HIV/AIDS with a recent CD4 count and 
medical history. The CD4 count needed to be tested recently so that an accurate 
relationship between CD4 count and presenting dysphagia symptoms could be 
established.  A recent CD4 count was important in order to prevent threats to the 
reliability and validity of the results. If a patient had an incorrect CD4 count, this would 
result in the patient being categorised in the incorrect stage of HIV/AIDS rendering the 
results of the study invalid and therefore unreliable. Patients at all stages of HIV/AIDS 
were included in this study because HIV/AIDS as a disease was being studied, not only 
patients at a particular stage of the disease.  
 
• The patients had to be alert and responsive in order to follow instructions and to give 
consent. Patients who were unable to give consent must have a family member to sign the 
consent on the patient’s behalf for ethical purposes. Only patients who had signed a 
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consent form would be allowed to participate. If a patient was rendered unresponsive or 
not alert, then this can negatively affect their ability to swallow (Logemann, 1997). This 
is because swallowing is a voluntary process and if the patient is no longer aware, then 
the swallowing mechanism is either ineffective or non-existent therefore leading to the 
risk of aspiration (Logemann, 1997). If the swallow was not able to be assessed 
adequately therefore resulting in inadequate data and invalid results.  
 
• Patients who were on Highly Active Anti Retroviral Therapy (HAART) were also 
included in this study. The majority of in-patients who are living with HIV/AIDS are on 
HAART, hence the inclusion of these patients in this study ensured that the sample was 
representative of the population (Arivieux & Michelet, 1998; Bourne & Bradshaw, 2005). 
Having patients who were on HAART, ensured that the findings were relevant to the 
context. It was also one of the variables that were analysed.  
 
3.3.2. Exclusion criteria for the bedside assessment (MASA) and modified barium swallow:  
• Patients who were under eighteen years of age as these patients are not yet considered 
adults.  
 
• Patients who exhibited a dysphagia but did not have HIV/AIDS. This is because the 
researcher would be unable to describe the effects HIV/AIDS had on the swallowing 
process.  
 
• Patients who did not have a recent CD4 count or up-to-date medical information. A recent 
CD4 count was when the result was achieved during the current hospital stay. An 
incorrect CD4 count would have yielded invalid and unreliable results and patients could 
have erroneously been categorised as being in the wrong stages of HIV/AIDS.  
 
• Patients who had a decreased level of consciousness or impaired cognition as the 
swallowing mechanism could not be analysed. This condition would result in inadequate 
data because patients who are unresponsive will not swallow adequately or perhaps not 
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swallow at all (Logeman, 1997).  
 
• Patients who were unable to follow instructions. The reason for this was because the 
patients would have been unable to follow the necessary instructions in order to perform 
the assessments.  
 
• Patients who had previous head or neck surgeries or conditions that could affect their 
swallowing ability. The reason for this is because the dysphagia would not purely be 
related to HIV/AIDS as the swallowing physiology would have possibly been altered as a 
result of the surgery (Logemann, 1997).  
 
 
3.3.3. Description of participants  
In total, 106 participants were assessed. 80 had undergone the MASA alone and 26 
underwent the MASA (Mann, 2002)and the MBS.  
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Table 5: Frequency and percentage of participants  
 n / 106 Frequency  %  
Male   83 78 
Female   23 22 
Age  
20- 30 
31-40 
41+  
 
 
 
64 
41 
  1 
 
60 
37 
  3 
CD4 count  
<250  
>250 - <500 
500 – 800 
>800 
  
87 
16 
  2 
  1 
 
82 
15 
  2 
  1 
HAART 
1a 
1b 
Other 
 22 
13 
  6 
  3 
21 
59 
27 
14 
 
The above table reveals that the majority of participants were between the ages of 30 – 40 
years. The largest portion of the participants had a CD4 count that placed them in the 
advanced stage of AIDS. There were only 22 participants who were on a HAART regimen 
and the most common regimen that participants were on is 1a.  
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3.3.4. Description of the different conditions seen in the data  
Figure 1: Frequency and percentages of the conditions in the data (n/ 106) 
 
The above figure reveals that there was an equal distribution of neurological and 
opportunistic infections that was seen among participants. There were a further 20% of 
participants that had numerous combinations of conditions. Please see Appendix F for the 
detailed table of the different combinations of conditions that were seen. Only 4% of 
participants had a condition that was not neurological or opportunistic in nature.  
 
3.4. Methods and Material 
3.4.1. Instruments 
The Mann Assessment of Swallowing Ability (MASA) (Mann, 2002) was used in this study. 
The MASA (Mann, 2002) was developed on neurologically impaired adult patients (e.g. 
stroke and Parkinson’s disease) in an acute hospital setting (Mann, 2002). The MASA (Mann, 
2002) was developed as there was a lack of standardised assessment tools in the area of adult 
dysphagia. The test was developed from the researcher using information from the standard 
bedside assessment and current literature at the time (Mann, 2002).  
 
The MASA (Mann, 2002) consisted of 24 items that were divided into of the following 
subsections:  
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Table 6: MASA subsections 
Area  Section  Rationale  
Demographics Age For the inclusion criteria 
Medical History CD4 count and diagnosis, 
level of alertness and 
respiratory status 
This information is necessary 
for the assessment procedure 
(Logemann, 1998). 
Patient Functioning  Alertness, Co-operation, 
auditory comprehension, 
respiration  
These areas are important to 
establish the assessment 
procedure (Mann, 2002). 
Evaluation of the Oromotor/ 
Sensory Components 
Aphasia, apraxia, dysarthria, 
saliva, lip seal, tongue 
movement,  strength and co-
ordination and oral preparation  
These areas are important to 
assess because they provide 
information pertaining to oral 
motor functioning, pre oral 
phase and whether the patient 
is at risk for possible 
aspiration (Perlman & Schulze 
– Delrieu, 1997).   
Functional Assessment of the 
Swallow  
Gag, palate, bolus clearance, 
oral transit, cough reflex, 
voluntary cough, voice, 
trachea, pharyngeal phase and 
response  
These areas assess the 
pharyngeal phase of the 
swallow (Mann, 2002). These 
areas will inform the therapist 
about the mode of feeding and 
whether a MBS is indicated 
(Cichero, 2006). 
Dietary/ Fluid 
Recommendations  
Consistencies the patient 
should eat  
The above information 
informs the therapist as to how 
to manage the patient 
according to the consistencies 
the patient can tolerate (Mann, 
2002).  
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All items are arranged from the pre-oral phase to the pharyngeal phase (Mann, 2002). All 
items have been chosen based on literature and clinical skills (Mann, 2002). The MASA can 
be conducted within 15-20 minutes and requires the use of a tongue depressor, torch, gloves 
and the following food consistencies: thin liquid, thick liquid, soft, semi – solid and solid.   
 
For the barium swallow the following apparatuses were be used: ultravist, barium, spoons, 
gloves, cups, straws, yoghurt and biscuits.  
 
3.4.2. Modified Barium Swallow Protocol  
The machine used for the barium swallows at the Helen Joseph Hospital was the Shimatusu 
Fluroscopy UD150L – 30F. 
 
Table 7: MBS protocol  
Area Materials Rationale  
Oral Phase Ultravist and barium This section looks at whether 
the patient is at risk for 
aspiration (Logemann, 1997).  
Pharyngeal Phase Ultravist and barium  This area is analysed to 
establish whether the patient is 
aspirating and if so, on what 
consistencies (Logemann, 
1997).  
Oesophageal Phase  Ultravist and barium  This area analyses whether the 
patient has any anatomical or 
physiological difficulties in the 
area of the oesophagus 
(Langley, 1997).   
Reflux   This is important to assess as 
the patient can aspirate on 
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Area Materials Rationale  
their reflux when in supine 
(Cichero, 2006).  
 
3.5. Procedure 
Description of the site  
The regional hospital treats acute adult patients only (above 12 years of age) and consists of 
10 medical wards, two of which are admission wards, 4 surgical wards and 1 psychiatric 
ward. The hospital caters for approximately 570 in-patients. The average medical intake is 45 
patients daily. The regional hospital has specialised units for in patients such as Intensive 
Care Unit (ICU) (intensive care unit), renal, cardiology, respiratory, palliative care and 
infectious control units. This regional hospital also has numerous out-patient departments 
such as ophthalmology, ear, nose and throat, orthopeadics, plastic surgery and family 
medicine as well as an HIV and TB focal points.  
 
The in-patients (sample) were referred to the speech therapy and audiology department from 
any member of the multidisciplinary team which included the doctors, physiotherapists, 
dieticians and occupational therapists. From the period of when ethical clearance was 
obtained the researcher began to assess all patients with the MASA (Mann, 2002).  
 
The researcher approached the patient at the bed, greeted the patient and informed them about 
the study. If the patient was not competent in English, the researcher utilised a trained 
research assistant to help the patient illicit appropriate responses to the questions. The nurses 
in the ward were informed about the study and the researcher trained them on what was 
required of them during the assessment. The nurses were requested to interpret exactly what 
the researcher said to the patient and exactly what the patient said to the researcher. The 
nurses interpreted into IsiZulu, IsiXhosa and SeSotho. Once the patient had signed the 
consent form then the researcher began assessing with the MASA (Phase 1). The researcher 
was the only person present during the assessment unless the interpreter was required. If the 
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therapist determined that the patient was able to follow instructions and had a dysphagia 
and/or was at risk for aspiration as per the results from the MASA, the patient was referred 
for a barium swallow in the radiology department and this is when phase 2 of the study 
commenced. The patient was informed about the barium swallow and what it entailed. The 
treating doctor would fill out an x-ray form. The patient was then taken from the ward to the 
x-ray department. The patient was required to stand in front of the x-ray equipment in a 
lateral position. A lateral position was best as it allows the radiologist to assess the oral cavity 
to the oesophagus clearly (Logemann, 1997). The radiologist analysed the images at two 
frames per second. The radiologist asked the patient to initially hold the 15ml of ultravist in 
their mouth, which is a water based soluble that can be detected on x-ray and to swallow on 
the radiologists command. The radiologist then requested and anterior-posterior view if it was 
deemed necessary which assessed whether pooling in the valleculae was present (Logemann, 
1997). The radiologist performed the barium swallow and the results were interpreted by both 
the researcher and the radiologist. The radiologist interpreted the control x-rays and looked 
for anatomical or physiological abnormalities in all phases of the swallow. The radiologists 
then asked the patient to lie in the supine position and would then look for reflux. If it was 
determined by the radiologist and the researcher that the patient tolerated the ultravist as there 
were no signs of aspiration, then the patient was asked to swallow 20ml of barium which 
could be made into different consistencies, if necessary, for therapeutic reasons. Different 
consistencies were assessed if the researcher felt there was a need to assess a particular 
consistency as based on the results from the bedside evaluation.   
 
Once the assessment had been completed, the researcher devised an appropriate treatment 
plan that best addressed the signs and symptoms of dysphagia displayed by the patient. The 
patient was placed on an appropriate diet and if seen to be tolerating the diet, the researcher 
informed the patient and/or their family about the research. 
 
3.6. Data Analysis 
The data was analysed using both inferential and descriptive statistical methods. Descriptive 
statistics summarise and describe data quantitatively (Punch, 2005). Descriptive statistics 
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simply describe what the data shows (Durrheim, et. al, 2006). The descriptive statistics that 
the researcher for this study employed were means and standard deviations.  
 
The inferential statistics that were used in this research study was Spearman Rho, Wilcoxon 
Rank Sum test, non-parametric ANOVA and independent sample t-test. Spearman Rho is a 
test that is used to find an association between two sets of ranks (Kaplan, 1997).  This test 
was therefore used to calculate inter-rater reliability for the MASA (Mann, 2002)  as well as 
to compare the results obtained on the MASA (Mann, 2002)and MBS. The Wilcoxon signed 
rank test was used when comparing two independent samples (Howell, 2002). It was used to 
analyse the difference between the participants’ conditions and the severity of the dysphagia. 
The Kruskal-Wallis Test which is the non-parametric test of ANOVA was used to analyse if 
there were any significant relationships between the different levels of CD4 counts of the 
participants and the signs and symptoms of dysphagia. The purpose of the Kruskal-Wallis test 
was to evaluate three or more sampling distributions of ranked data (Kaplan, 1997). The 
Kruskal-Wallis test was appropriate for question 3 as there were 4 groups of different CD4 
count levels. The last question was addressed using The Mann-Whitney U test which is the 
non parametric counter part of the t-test. This test is used to determine if there is a statistical 
difference of the mean between two groups (Kaplan, 1997). This test was used to analyse if 
there was a significant difference between the signs and symptoms of dysphagia between the 
participants who were on a HAART regimen and those who were not.  
 
3.7. Ethical clearance  
Ethical clearance number: M091165 
Once ethical clearance had been obtained from the Human Research Ethics Committee, the 
University of the Witwatersrand and the regional hospital, then the data collection 
commenced. Please see Appendix C for the ethical clearance certificate.  
The researcher was required to follow the under mentioned ethical principles, as set out by 
the Health Professions Council of South Africa, while this research was conducted: 
1. Autonomy: is the patient’s right to independent actions and choices. In this study the 
patient and/or family will be involved in all the decisions regarding assessment and 
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treatment. The patient will be allowed not to participate in the research or to withdraw 
their participation at any point.  
2. Beneficence: the obligation to act in the patient’s best interest. The patients in this 
study will be assessed and managed accordingly by the relevant multidisciplinary 
team members. All patients were managed whether or not they choose to participate 
in the study. As this population is considered to vulnerable because the patients are ill, 
it is important that the patient is managed prior to being asked to be included in this 
study (Bigatello, George & Hurford, 2003). 
3. Non-maleficence: this is the obligation not to inflict harm on the patient. As per the 
beneficence topic, the decisions will be made within the team and in the patient’s best 
interest. The patient will not be sent for a barium swallow if the patient does not meet 
the inclusion criteria.  
4. Justice: refers to the lifting and assisting those in the team with their work load. The 
decisions will be made accordingly to the patient’s best interest with their or their 
families’ involvement.  
5. Confidentiality: refers to any information that is given by the patient will remain 
confidential. In this study, the information will only be shared amongst relevant team 
members to help with the assessment and management of the patient. The patient’s 
name will not be used in the study as the patients will be assigned a number in the 
data. The data was locked in a cabinet after the analysis was conducted.  
 
3.8. Reliability & Validity 
3.8.1. Reliability  
Reliability is defined as the consistency with which a measuring instrument yields a certain 
result when the entity being measured has not changed (Leedy & Ormrod, 2005). Due to the 
nature of the MASA (Mann, 2002) being an ordinal scale, internal consistency could not be 
analysed. When the researcher assessed the assumptions of normality, the null hypothesis was 
rejected as the results were skew and this also contributed to the internal consistency of the 
MASA not being able to be determined. The researcher therefore conducted an inter-rater 
reliability test. For this a Spearman Rho test was conducted. This statistical measure is used 
to find an association between two sets of ranks (Kaplan, 1997). 
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Table 8: Inter – rater reliability 
 
Rater 1 
Rater 2  Alertness  Aud 
Comp 
Resp Tong 
strength 
Oral 
phase 
Phary 
Phase  
 
Alertness  - - - - - -  
Aud 
comp 
- 1 
<.0001 
- - -0.08 
0.7867 
-  
Resp - - - - - -  
Tong 
Strength 
- 0.083 
0.7867 
- - -0.08 
0.7867 
-  
Oral  
Phase 
- - - - -0.123 
0.6887 
-  
Pharyn 
Phase  
- - - - - -  
Table key: 
Aud comp – auditory comprehension  
Resp – respiration 
Tong strength – tongue strength  
Pharyn phase – pharyngeal phase  
 
The findings from this test indicated that the MASA (Mann, 2002) was a reliable tool to 
conduct a bedside dysphagia assessment as there was a high level of agreement between the 
two raters. The two raters only had 6 differences in scores on the MASA (Mann, 2002) out of 
a total of 25. The insignificant p-value (greater than 0.05) results implied that the levels did 
not differ significantly. This therefore concludes that the MASA had good inter rater-
reliability.  
 
3.8.1.1. Pilot Study  
As the MASA (Mann, 2002)had not been assessed on a South African population, the 
researcher needed to conduct a pilot study. Haralambos & Holborn (2000) state that a pilot 
study is conducted prior to the main study in order to check the feasibility, therefore this pilot 
study was conducted to determine the suitability for HIV/AIDS patients or to improve on the 
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research design. A pilot study could also be used to check reliability and validity of the 
results (Haralambos & Holborn, 2000).  
 
3.8.1.2. Questions of the pilot study: 
1. Was the MASA (Mann, 2002) an appropriate assessment tool to be used on the 
HIV/AIDS population in an acute hospital setting in terms of the questions that were 
used.  
2. Was the MASA (Mann, 2002) a reliable and valid assessment tool? 
 
3.8.1.3. Research design 
The pilot study followed the same research design as the main study which was a descriptive, 
cross-sectional, quasi non-experimental design.  
 
3.8.1.4. Sample and sampling method  
The pilot study utilised 20 in-patients that had been referred to the speech therapy & 
audiology department who had been diagnosed as living with HIV/AIDS. The pilot study 
followed the same sample and sampling method as used for the main study.  The main study 
utilized a non-probability sampling method as the sample was not chosen randomly. This was 
due to the fact that the sample was a convenience/purposive  sample selected on the basis of 
HIV patients who exhibit dysphagia in the ward. The same inclusion and exclusion criteria 
that were used for the main study was used in the pilot study.  
 
3.8.1.5. Materials  
The researcher utilised the MASA (Mann, 2002)  for the bedside assessments in the pilot 
study as this was the tool that was being evaluated for its reliability and validity. The details 
for the MASA are seen under the main study.  
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3.8.1.6. Procedure 
The researcher received the referral and assessed the patient within a 24 hour period. The 
researcher then enlisted the assistance of another therapist within the department to re-test 
25% of the patients with the MASA (Mann, 2002), for inter-rater reliability (Rosnow & 
Rosenthal, 2002). The patients were re-tested 24 hours later. As patients with an advanced 
HIV/AIDS condition can change in a short period of time, it was important for the 
assessments to be close together to avoid different results being obtained (Arivieux & 
Michelet, 1998). The same procedure for assessing with the MASA (Mann, 2002), as 
described above for the main study, was utilised in the pilot study by both the researcher and 
the assistant therapist.  
 
3.8.1.7. Threats to reliability and validity  
Based on the results of the pilot study, the MASA (Mann, 2002)  was an appropriate tool to 
use in an acute care setting in South Africa as there were no test items that are inappropriate. 
Therefore this rendered the results that were obtained by the MASA (Mann, 2002) valid. 
 
The MASA (Mann, 2002) was an appropriate assessment tool for patients with and without a 
neurological disorder. Therefore the validity of the results was not affected.  The researcher 
did not need to change the instructions of the MASA (Mann, 2002).  While assessing the 
inter-rater reliability, the disagreements may be attributed to random error. As seen above, the 
Spearman Rho test revealed that the MASA (Mann, 2002) was a reliable tool to use.  
 
3.8.1.8. Results  
It was noted during the pilot study that the MASA (Mann, 2002) did not have a section which 
allows the speech therapist to assess the oesophageal phase of the swallow. The researcher 
therefore had to assess the oesophageal phase informally based on the patients’ description of 
their signs and symptoms. For example: the patients that were diagnosed with candida often 
described odynophagia.  
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3.8.2. Validity  
Validity is defined as the extent to which the instrument measures what it is supposed to 
measure (Leedy & Prmod, 2005). The MASA (Mann, 2002)  possesses adequate content and 
face validity (Mann, 2002). Content validity refers to the test items representing the kinds of 
material that they are supposed to measure (Rosnow & Rosenthal, 2002). Face validity refers 
to whether the test measures what is relevant (Rosnow & Rosenthal, 2002). The MASA 
(Mann, 2002)  was compared against other standardised tests and proved to have similar 
items in the test. Therefore the MASA (Mann, 2002) has good content validity (Mann, 
2002).The MASA (Mann, 2002) was developed by asking experts in the area of dysphagia to 
identify items that were worthy of inclusion. These items were then adjusted accordingly by 
the experts (Mann, 2002). This implied that the MASA (Mann, 2002) had good face validity. 
The MASA also had good criterion and concurrent validity (Mann, 2002). Criterion validity 
refers to the degree to which the test correlates with one or more outcome criteria (Rosnow & 
Rosenthal, 2002). The good criterion was because the MASA (Mann, 2002) results were 
compared to the videofluroscopy results and shown to yield similar results. As 
videofluoroscopy is the gold standard in objective dysphagia assessments, it showed that the 
MASAhad good criterion validity (Mann, 2002).   
 
Furthermore, when it was applicable, the results obtained from the MASA (Mann, 2002  were 
compared to the modified barium swallow findings to check the validity of the results. This 
improved the concurrent validity of the study. Concurrent validity refers to the degree to 
which the new measure is related to pre-existing measures of the construct (Punch, 2005). 
As the MASA (Mann, 2002) was developed on neurologically impaired adult (stroke) 
patients in a hospital setting, this study should have good external validity as there are large 
numbers of patients who are living with HIV/AIDS that have a neurological impairment. 
External validity is defined as the ability for the sample outcomes to be generalised to the 
population outside the circumstances of the study.  
 
Based on the results of the Spearman Rho test, when the results from the two raters were 
compared, the MASA (Mann, 2002) was deemed to be an appropriate tool to use in an acute 
care setting in South Africa.  
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4. RESULTS 
The main aim of the current study was to assess the effects that different medical conditions 
can have on dysphagia in adults who are living with HIV/AIDS.  
 
The specific questions for this study were: 
1. What were the signs and symptoms of dysphagia and odynophagia in adults who are 
living with HIV/AIDS?  
2. Was there a difference between the obtained signs and symptoms of the patients with 
neurological versus opportunistic infections?  
3. Was there a relationship between the variables of age, CD4 count and HAART regimens 
to the severity of the dysphagia? 
4. Did the results of the Mann Assessment of Swallowing Ability (MASA) (Mann, 2002) 
significantly correlate with the results of the Modified Barium Swallow (MBS)?  
Additionally, as stated above, the current study investigated the reliability of the MASA as an 
assessment tool because it was one of the measures adopted in the methodological section. In 
order to address these research questions the data was analysed using descriptive as well as 
inferential statistics.  
 
The results have been discussed by firstly presenting data that offers a description of the 
sample, followed by the specific findings of the current research, in accordance with the 
specific questions. The researcher interrogates the nature of the data and suitability of the 
methods and the statistical methods adopted.   
 
4.1. Inter- rater reliability results  
As seen in the methodology section, an inter-rater reliability test was done and the results 
were analysed using the Spearman Rho test. The results from this test revealed that as the 
inter-rater reliability was strong, it can be concluded that the Mann Assessment of 
Swallowing Ability (MASA) (Mann, 2002) was therefore a reliable assessment tool that can 
be used on acute patients for a bedside assessment.  
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General description of the participants according to the conditions that were seen in the 
data  
In total there were 106 participants that were assessed. 80 participants had a bedside 
assessment only and 26 participants underwent a bedside assessment as well as a modified 
barium swallow. The table below shows the participants according to age and gender.  
 
Table 9: Frequency analysis of participants  
n/106          Age       F % 
20-29 32 33 
30-39 33 35 
40-49 39 41 
50-59 2 2 
60+ 1 1 
Gender   
Male  83 78 
Female  23 22 
The above table revealed that there were more males seen in the data than females and most 
participants were between the ages of 40 - 49.  
 
4.2. CD4 counts & HAART regimens of participants  
As part of the inclusion criteria for this study, the participant was required to have a recent 
CD4 count and it was also noted whether the participant was on a HAART regimen.  
 
Table 10: Distribution of CD4 counts among participants and numbers of participants on 
HAART 
CD4 count   n/ 106   F % HAART  n/22  F %  
>800     1 0.8    0 0 
<800 but >500    2 1.8    1 4 
<500 but >250    16 15    5 23  
<250     87 82    16 73 
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The data in table 10 revealed that the majority of participants were in the advanced stages 
(CD4 count of less than 250/mm3) of the disease and only one participant was in the 
beginning (HIV +) stage (CD4 count of greater than 500/mm3) of the disease. This table also 
highlights that out of the 106 participants, only 22 were on a HAART regimen and the 
majority of the participants who were on a regimen were in the advanced stages of AIDS. 
This was to be expected as the majority of the participants were in the advanced stages of the 
disease.  
 
In HAART, there are different combinations of drugs called regimens. As stated in the 
literature, for regimen 1a and 1b the drug combination consists of 2 NRTI’s (nucleoside 
reverse transcriptase inhibitors) with 1NNRTIs (non-necleoside reverse transcriptase 
inhibitors). There are numerous NRT’s and NNRTIs available in South Africa. The table 
below reveals the different combinations of drugs seen in the different regimens as seen in 
the data.  
 
Table 11: HAART regiment as seen in the data  
HAART regimen   n/22 F % 
1a 12 55 
1b 6 27 
Other 4 18 
 
The above table revealed that the most common regimen was 1a. These results were 
unexpected in that it was anticipated that more participants would have been on a HAART 
regimen as the majority of the participants were in the advanced stages of HIV/AIDS. A 
detailed list of all the different combinations that were found in the data can be seen in 
Appendix F.  
 
Table 12 below shows the participants according to  the specific diagnosis with which they 
presented. Any condition that was bacterial in nature but had a neurological effect was 
considered to be a neurological condition e.g. tuberculosis meningitis or cryptococcal 
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meningitis. Any condition that did not have an effect on the CNS was considered to be either 
opportunistic, HAART side effects or other.  
 
Table 12: Description of participants according to diagnosis  
Conditions    n/ 106  F % Conditions    F % 
 Neurological     38 36      Opportunistic infections  38 36 
CVA     24 24           Pulmonary TB   16 16 
Myelopathy    2   2         Oropharyngeal candida  11 11 
Cryptoccal meningitis    8   8         Chest infections   66 
Tuberculosis meningitis   4   4         Gastroenteritis    5 5 
Pontocerebellar syndrome   1    1         Vancellar zoster   1  1 
                   Kaposi sarcoma   1 1 
Other      3  Combinations    24  
 
4.3. Research questions: 
4.3.1. What were the signs & symptoms of dysphagia and odynophagia in adults who are 
living with HIV/AIDS.  
 
4.3.1.1. Descriptive statistics  
For this study, the researcher utilised means, ranges and standard deviations in order to draw 
conclusions from the data.  
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Table 13: Signs of dysphagia as seen on the MASA for neurological conditions and 
opportunistic infections  
     Neurological conditions  Opportunistic infections 
      n/106     F  %   F   % 
Auditory Comprehension  15  14   5  5 
Respiration     3  3   3  3 
Oral Phase     45  42   21  20 
Pharyngeal Phase    19  18     8  8 
Oesophageal phase      7  7     6  5 
 
The above table indicates that although all phases of swallowing seem to be affected in 
HIV/AIDS, the oral phase was the most commonly affected. The oral phase of swallowing 
was the most affected irrespective of diagnosis. Some participants had more than one 
symptom and therefore the total frequency is slightly more than 106.  
 
Table 14: Symptoms of dysphagia as seen on the modified barium swallow results for 
neurological and opportunistic infections  
     Neurological conditions  Opportunistic infections  
   n/26        F   %  F           % 
Oral Phase          13   50  4                 15.3 
Pharyngeal Phase         17  65.3  3         11.5 
Oesophageal phase           5  19.2  2          7.6 
 
This table highlights that participants who had a neurological condition displayed more 
symptoms of dysphagia at all phases as compared to participants who had an opportunistic 
infection. These results of the signs of dysphagia were similar to those observed on the 
MASA (Mann, 2002). However, the MBS results showed a slightly higher percentage of 
patients with pharyngeal phase difficulties than the MASA (Mann, 2002) which relies more 
heavily on subjective observation. Overall, participants with a neurological condition 
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displayed more signs and symptoms of dysphagia than the participants who had an 
opportunistic infection.  
Table 15: Overall means and standard deviations of signs and symptoms of dysphagia for all 
participants in the data  
Signs/Phase of swallow n/106   Total score  M  SD   
Alertness          349             90.80   0.85 
Auditory Comprehension        341             90.25   1.49 
Respiration          353   90.70   1.19 
Dysarthria         4545   50.44  2.44  
Oral Phase        7898             74.91            10.33 
Lip movement        4660   54.19  0.91 
Tongue movement        4693   52.25  2.3 
Pharyngeal Phase       6115   57.88  7.40 
Oesophageal Phase             303  20.92  0.26 
 
From the results of table 15, it is evident that the majority of participants experienced 
difficulties in the oral phase, specifically with lip and tongue movement. It is also apparent 
that a significant proportion of the population has dysarthria. The weakness that results in the 
dysarthria could also cause oral phase difficulties. There are some participants who 
experienced bolus clearance and oral transit difficulties. There appear to be significantly 
fewer participants who experienced pharyngeal phase difficulties. Some participants 
presented with odynophagia or multiple swallows.  
 
In summary, participants who are diagnosed with HIV/AIDS irrespective of co-morbid 
conditions present with signs or symptoms of dysphagia.  
 
4.3.1.2. Assumptions of normality  
When assessing the null hypothesis, the p-value was significant (less than 0.05) and therefore 
the null hypothesis was rejected and it was concluded that the data was not normally 
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distributed. Due to this lack of normal distribution within the data, non-parametric tests were 
utilised for all the inferential data analysis procedures. The majority of the data appeared to 
be skewed in a positive manner. Please see histograms in Appendix E for data from the 
MASA (Mann, 2002). As the MASA presented data that was in an ordinal scale format, non-
parametric tests also had to be used as this data type affected the assumptions of normality.  
 
4.3.1.3. Inferential statistics 
The inferential statistics test that was used to answer this question was the Wilcoxon 
rank sum test. This test is a non-parametric test used to measure two independent 
samples (Howell, 2002).  
 
4.3.2. Was there a difference in the severity of the signs and symptoms of dysphagia on the 
MASA (Mann, 2002) and MBS according to the diagnosis (neurological or 
opportunistic infections) of the patient?  
 
4.3.2.1. Inferential statistics  
The Wilcoxon signed rank test was used when comparing two independent samples 
(Howell, 2002). It was used to analyse the difference between the participants’ 
conditions and the severity of the dysphagia. 
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Table 16: Wilcoxon signed rank test for establishing a relationship between signs of 
dysphagia and the participants’ condition (significance of 0.05) 
 
n/ 106 Neurological Conditions Opportunistic Infections 
 Mean of Ranks  Z p - value  Mean of Ranks  Z P - value 
Auditory 
Comprehension 
 
56.39 
 
-3.4 
 
0.0009 
- - - 
 
Dysarthria 
 
39.44 
 
-4.04 
 
0.0001 
- - - 
 
Lip movement 
 
44.48 
 
-2.67 
 
0.0080 
- - - 
 
Oral Preparation 
 
45.55 
 
-2.9 
 
0.0045 
- - - 
 
Bolus Clearance 
 
 
41.92 
 
-4.2 
 
<0.0001 
- - - 
Voice 46.54 -2.5 0.0120 - - - 
 
Pharyngeal Phase 
 
42.38 
 
-2.7 
 
0.006 
- - - 
 
Poor laryngeal 
elevation  
- - -  
53.5 
 
1.99 
 
0.0487 
 
Oesophageal phase 
 
47 
 
-2.20 
 
0.030 
- - - 
 
The above table reveals that participants with a neurological condition experienced 
significantly more symptoms of dysphagia than those participants who had an opportunistic 
infection, except with laryngeal elevation. Based on the above statistics, the null hypothesis 
was therefore rejected.  
 
4.3.3. Was there a difference between the variables of age, CD4 counts and being on a 
HAART regimen of the participants and the severity of the dysphagia on the MASA 
(Mann, 2002)  and MBS? 
 
4.3.3.1. Age 
The Wilcoxon signed rank test was used to assess if there was a difference between 
the age of the participants and the signs of dysphagia. A p-value of 0.05 was taken as 
a significant result.  
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Table 17: Wilcoxon rank sum test for signs of dysphagia and age  
 n/106 Mean Rank Z p- value 
Aud 
Comprehension 
 
 
9.250 
 
-0.234 
 
   0.0353 
Respiration  9.700 -0.11 0.317 
Dysarthria   3.912 -0.41 0.001 
Oral Phase  3.993 -0.23       0.010 
Pharyngeal Phase  3.812 0.09       0.100 
Oesophageal phase  2.925 -0.03 0.733 
Table key:  
Aud comprehension : auditory comprehension  
 
The above table shows that the p-values were significant for dysarthria and the oral phase. 
These results imply that dysarthria and oral phase difficulties were more significant in 
participants who were older. Based on these results, the null hypothesis was therefore 
rejected.  
 
4.3.3.2. CD4 count  
For this variable, the Kruskal-Wallis test was used. This was because there were four CD4 
count categories. The categories were as follows as stated in the literature review: 0 – less 
than 250/mm3, 1 – more than 250/mm3 but less than 500/mm3, 2 – more than 500/mm3 but 
less than 800mm3, 3 – more than 800mm3.  
Table 18: Kruskal – Wallis Test for CD4 count and signs and symptoms of dysphagia  
n/106 Sum of 
Squares 
df Mean 
Square 
p – value  
Aud comp 4610.00 3 53.60 0.120 
Respiration  706.00 3 44.12 0.030 
Dysarthria  4545.00 3 52.84 0.770 
Oral phase 4647.50 3 54.04 0.190 
Pharyngeal 
phase  
4526.50 3 52.63 0.157 
Voice  2.50 3 2.50 0.002 
Oesophageal 
phase  
4562.50 3 53.05 0.904 
Table key:  
Aud comprehension: auditory comprehension  
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The above table highlights that there was a significant relationship between respiration and 
voice for the variable of CD4 count. This implies that the lower the CD4 count is, the more 
significant the symptoms are for respiration and voice. Therefore, the null hypothesis was 
rejected.  
 
4.3.3.3. HAART regimen  
For this variable, a Mann-Whitney U test was used as there were only two groups, those 
participants who were on ARV’s and those who were not.  
 
Table 19: Mann – Whitney U for HAART regimen and signs and symptoms of dysphagia  
 
 
 
Table key: 
Aud comp: auditory comprehension  
 
Based on the above results, participants who were 
on a HAART regimen appeared to experience more 
significant pharyngeal phase symptoms, a more 
severe cough and aspirated more than those participants who were not on a HAART regimen. 
Based on these results the null hypothesis was rejected.  
 
4.3.4. Did the results of the MASA significantly correlate with the results of the MBS?  
For this question to be analyzed, the Spearman Rho test was used. This test is used to find an 
association between two sets of ranks (Kaplan, 1997). The closer the p-value is to 0, the 
stronger the correlation. A p-value was less than 0.05 therefore implied that there was a 
significant relationship between the following MASA (Mann, 2002) symptoms and modified 
barium swallow symptoms: Please see the Spearman Rho table on the next page 
n/106 Z P – 
value 
Aud comp  -1.55 0.11 
Oral phase  -0.69 0.48 
Pharyngeal 
phase  
-1.95 0.05 
Cough  -2.14 0.01 
Laryngeal 
elevation 
-0.77 0.42 
Oesophageal  
phase 
-0.77 0.43 
Aspiration  -2.36 0.01 
 63 
 
Table 20: Spearman Rho test for the MASA and MBS results  
MBS 
 
MASA  
Delay 
oral 
onset  
Bolus 
form  
Bolus 
prop  
Tongue 
mvt  
Residue 
floor  
Delay 
trig  
Pooling Aspiration Reflux  Nasal  
regurg 
Aud 
comp 
 
0.190 
0.357 
 
-0.100 
0.600 
 
-0.100 
0.060 
 
-0.120 
  0.540 
 
-0.080 
0.679 
 
-0.160 
 0.431 
 
0.290 
0.158 
 
-0.200 
 0.332 
 
-0.183 
0.378 
 
0.060 
0.775 
Table key: 
Resp 
 
0.177 
0.395 
 
0.326 
0.111 
 
0.326 
0.111 
 
0.271 
0.188 
 
0.434 
0.030 
 
0.098 
0.638 
 
0.291 
0.158 
 
0.101 
0.630 
 
0.157 
0.452 
 
0.060                  aud comp: auditory comprehension 
0.775                  resp: respiration  
Dysart
hria 
 
0.137 
0.512 
 
0.483 
0.014 
 
0.483 
0.014 
 
0.374 
0.065 
 
0.084 
0.687 
 
0.073 
0.725 
 
-0.040 
  0.848 
 
0.021 
0.920 
 
0.145 
0.485 
 
-0.267                lip mvt: lip movement  
0.1960               tong mvt: tongue movement  
 
Lip 
Mvt 
  
 
-0.005 
0.979 
 
-0.045 
0.8290 
 
-0.045 
0.8290 
 
-0.053 
0.7990 
 
0.380 
0.068 
 
0.165 
0.428 
 
0.273 
0.185 
 
-0.840 
 0.688 
 
-0.328 
  0.109 
 
0.025                 tong strength: tongue strength  
0.905                 tong co – ord: tongue co – ordination  
Tong 
mvt 
 
0.091 
0.664 
 
0.452 
0.023 
 
0.452 
0.023 
 
0.533 
0.006 
 
0.361 
0.076 
 
0.091 
0.664 
 
0.451 
0.023 
 
-0.210 
  0.313 
 
-0.145 
  0.487 
 
0.166               multiple sw: multiple swallows 
0.425               oesophageal: oesophageal phase 
 
Tong 
strengt
h  
 
0.139 
0.505 
 
0.492 
0.012 
 
0.492 
0.012 
 
0.580 
0.002 
 
0.393 
0.051 
 
0.139 
0.505 
 
0.494 
0.012 
 
-0.157 
0.453 
 
-0.282 
0.171 
 
0.153               bolus prop: bolus propulsion 
0.465               nasal regurg: nasal regurgitation 
 
Tong 
co-ord 
 
0.091 
0.664 
 
0.452 
0.023 
 
0.452 
0.023 
 
0.533 
0.006 
 
0.363 
0.076 
 
0.091 
0.664 
         
0.451 
0.023 
 
-0.210 
  0.313 
 
-0.140 
 0.484 
 
0.041 
0.843 
 
Multipl
e sw 
 
-0.321 
 0.117 
 
-0.621 
0.0009 
 
-0.621 
0.0009 
 
-0.535 
0.005 
 
0.108 
0.604 
 
-0.389 
0.054 
 
0.136 
0.516 
 
-0.010 
0.960 
 
-0.043 
0.835 
 
-0.075 
 0.720 
 
Oesoph
ageal  
 
0.688 
0.0001 
0.242 
0.24 
0.242 
0.243 
0.187 
0.369 
0.344 
0.091 
0.619 
0.001 
0.211 
0.309 
0.538 
0.005 
0.318 
0.121 
0.075 
0.720 
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This table shows that there were numerous significant correlations between the symptoms 
described on the MASA (Mann, 2002) and the symptoms that were obtained from the MBS. 
This implies that the MASA (Mann, 2002) was a reliable bedside tool for detecting signs and 
symptoms of dysphagia. It also indicated that the MASA (Mann, 2002)  was just as reliable 
as a modified barium swallow in detecting a dysphagia.  
 
4.4. Summary of findings   
Based on the above results, patients who presented with a neurological complication 
appeared to present with more severe signs and symptoms of dysphagia especially in the 
areas of auditory comprehension, dysarthria, lip movement, oral preparation, bolus clearance, 
voice, pharyngeal phase and oesophageal phase. The participants’ CD4 count did not appear 
to make a difference in terms of symptomotology except that respiration difficulties appeared 
to be more severe, which therefore affected their vocal quality. In terms of age, older 
participants had more severe symptoms for dysarthria and oral preparation. Interestingly, 
participants who were on a HAART regimen experienced increased difficulty in the 
pharyngeal phase and aspirated more frequently. Very importantly, the MASA (Mann, 2002) 
and the MBS results had a strong correlation for numerous symptoms and therefore the 
MASA (Mann, 2002)  was a reliable tool that can be used for subjective and objective 
bedside dysphagia assessments.  
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5. DISCUSSION 
In summary, descriptively, the results revealed that participants with a neurological condition 
appeared to present with more severe signs and symptoms of dysphagia. The results from the 
Wilcoxon signed rank test showed that participants with a neurological disorder experienced 
more severe signs and symptoms of dysphagia, except with laryngeal elevation. The 
Wilcoxon signed rank test also showed that older participants experienced more dysarthria 
and oral transit difficulties. The results from the Kruskal-Wallis test highlighted that 
participants with a lower CD4 count had more significant respiration and voice difficulties. 
The results from the Mann-Whitney-U test showed that participants who were on a HAART 
regimen experienced increased difficulty in the pharyngeal phase and aspirated more 
frequently. The Spearman-Rho test results showed that the MASA (Mann, 2002) was seen as 
a valid bedside assessment tool for assessing adult dysphagia in an acute hospital setting.  
 
The discussion section broadly discusses the general findings of the study and will then look 
at the specific findings of each research question.  
 
5.1. Profile of the sample for the current study  
5.1.1. Demographics  
5.1.1.1. Gender 
This study found that there were significantly more men than women. Statistics South Africa 
(2010) showed that 19,7% of the adults who are living with HIV/AIDS were female and 
therefore 80.3% were male. This emphasises the fact that the findings from this study are in 
agreement with the current statistics as the majority of people who are living with HIV/AIDS 
are male. These findings are in contrast to an audiological study that was conducted at 
another Johannesburg public hospital which had significantly more females in the study but 
the participants were out patients (Khoza, 2008). These findings could indicate that the 
females are more common in out-patient settings whereas, males are more common as in-
patients.  
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5.1.1.2. Age 
Statistics South Africa (2010) revealed that the largest age group of people who were infected 
with HIV/AIDS was between 15 and 49 years of age. This is in agreement with the findings 
of this study which highlighted that the majority of participants who were seen to be living 
with HIV/AIDS were between 30 and 39 years of age. This shows that the majority of people 
who are living with HIV/AIDS in South Africa are within child bearing years and are within 
the age group that could be employed..  
 
5.1.1.3. HAART as seen in the demographics of the participants  
The majority of participants in this study were in the advanced stages of AIDS. Only 22 
(23%) participants were observed to be on HAART in this study. This is a true reflection of 
the South African HIV/AIDS population because in February 2011 the USAID team reported 
that out of the 50.4 million people who are infected with HIV/AIDS only 917 700 individuals 
are receiving HAART. It is unfortunate that the majority of people who are in the advanced 
stages of the disease were not on HAART as the latest South African policy declares that all 
people who have a CD4 count of below 350/mm3 should start on a HAART regimen (Barker, 
Leydon, Moleko, Osih, Venter & Webster, 2010). These results therefore imply that 
individuals are possibly not having check-ups and are only being initially diagnosed once 
they have entered into the final stages of the disease. The most common HAART regimen 
that was seen in the data was regime 1a (D4T/3TC/ EFV). There were also different 
combinations of drugs that were seen in the data that were not typically reported in the 
literature such as TENOFIVIR/3TC/NVP, TENOFIVIR/ 3TC/STAVUDINE, EFV/AZT/3TC 
and EFV/3TC. However, it should be noted that more people should be receiving HAART 
based on the CD4 counts seen in the data. The research discovered that most participants who 
were seen as in patients were newly diagnosed and therefore most of these patients have not 
yet started on a HAART regimen. It is also noted that these patients were in the advanced 
stages of the disease and possibly only sought help once they presented with symptoms.  
 
In summary, the sample that was obtained for this study was representative of the South 
Africans who are living with HIV/AIDS.  
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5.1.2. Various diagnoses as seen in the sample  
As based on the results from this study, there was an equal number  of participants who 
suffered from a neurological impairment and different opportunistic infections. There was a 
mix of conditions of participants who experienced respiratory difficulties i.e. both 
neurological and opportunistic infections. There was only one respiratory condition that was 
seen in the data which was pulmonary TB. The neurological conditions such as CVA, 
cryptococcal meningitis and TB meningitis were seen to have some respiratory difficulties. 
There is a close association between adequate respiration and dysphagia (Logemann, 1997). 
Breathing is controlled by the brainstem and if there is a neurological impairment, it may lead 
to possible respiratory difficulties and these could lead to aspiration (Cichero, 2006).  Kaposi 
sarcoma can lead to a possible airway obstruction (Federele, Sooy & Wall, 1986).  Therefore, 
these results are accounted for in the literature.  
 
This is in agreement with the literature because each phase of swallowing can be affected by 
both neurological deficits, opportunistic infections and as a result of the side effects of 
HAART.  
 
5.1.2.1. The effects on swallowing from neurological deficits  
Berger &Cohen (2007) highlighted that the brain was the second most common organ to be 
affected by the HI virus, second only to the lungs. The virus is able to cross the blood brain 
barrier and can therefore lead to changes in white matter of the brain which can affect the 
functioning of the cranial nerves and blood vessels (Brew, 2007). This can result in dementia, 
stroke, meningitis and vasculopathies (Bryer, Candy, De Villiers, Tipping & Wainwright, 
2007). As a result of these neurological conditions, a patient can have a dysphagia 
(Logemann, 1997). The results from this study revealed that CVA was the most common 
neurological condition seen among patients. This is in agreement with the findings from 
Mochan, Modi and Modi (2010) who conducted a study in South Africa and found that up to 
40% of people who are living with HIV/AIDS had a CVA. As expected, as a result of the 
CVA, the majority of these patients did experience some form of dysphagia.  
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The CNS can also be affected by various opportunistic infections. Some bacterial infections 
include: meningitis, herpes simplex and toxoplasmosis. The most common bacterial infection 
found in patients who are living with HIV/AIDS is reported to be bacterial meningitis (Berger 
&Cohen, 2007). This is in support of the findings of the study as the most common infection 
of the CNS was seen to be bacterial meningitis followed by tuberculosis meningitis. These 
results reflect the conclusions made by Singh & Vaidyanathanl (2003) who stated that TB is 
the most common serious opportunistic infection in HIV positive patients and is the 
manifestation of AIDS in more than 50% of cases in developing countries.  
 
5.1.2.2. The effects on swallowing from opportunistic infections  
The most common fungal infection that can occur in a patient who is living with HIV/AIDS 
is candida (Anteyi et. al, 2003).  The most common oral manifestation found in numerous 
studies done in both developed and developing countries was oral candida (Besige, et. al, 
2003; Bhojwani & Prasad, 2006 & Gillespie, 1993). These studies have also stated that 
candida can lead to dysphagia and odynophagia. The results from this study are in agreement 
with the literature which shows that candida is common amongst people who are living with 
HIV/AIDS. The study that was conducted by Arendorf et. al. (1998) concluded that oral 
manifestations are common features in the South African HIV/AIDS population. It was 
shown to be the second most common infection after pulmonary tuberculosis. These results 
were to be expected because according to a study by Devi, Devi, Naorem, Prasad Singh and 
Singh (2010) up to 55% of their participants in India who were living with HIV/AIDS had 
pulmonary TB. 
 
The numerous viral infections that can occur in a patient living with HIV/AIDS are: 
meningitis, Guillen-Barre syndrome, cytomegalovirus as well as viruses that can lead to 
encephalopathies and myopathies (Brew, 2007). The results reveal that meningitis is a more 
common occurrence in the HIV/AIDS population than myopathies. However, these results do 
support the findings as seen in the literature.  
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In some cases, opportunistic infections can become malignant such as in the case of Kaposi 
sarcoma and squamous cell carcinoma (Besige, et. al, 2003). There was only one case in the 
data where an individual suffered from Kaposi Sarcoma. This shows that malignancies do 
occur in this population but are infrequent. These malignancies can result in a dysphagia and 
need to be managed accordingly.  
 
5.1.2.3. The effects on swallowing as a result of HAART  
Most HAART regimens that patients with HIV/AIDS have to take have been known to have 
side effects that can lead to possible dysphagia (Daly, 2004). Some of these side effects 
include: nausea, vomiting, GI upsets, gastro-oesophageal reflux disease (GORD) and taste 
aversions (Van Dyk, 2008). The data revealed that there were no signs or symptoms of 
dysphagia seen as a result of the side effects from HAART.  
 
5.2. Research questions  
5.2.1. Signs & symptoms of dysphagia in people who are living with HIV/AIDS 
In addressing the question of the signs and symptoms of dysphagia in people who are living 
with HIV/AIDS, the following results were found:  
The majority of participants (22%) who displayed some form of dysarthria had a neurological 
condition such as CVA, meningitis, TB meningitis or pontocerebellar syndrome. This is in 
line with current literature because speech is controlled by various neurological pathways and 
numerous focal lesions can result in a speech disorder (Damasio, 2001). One participant with 
candida also experienced dysarthria and this could be as a result of pain during oral 
movement (Bhojwani, Chandra Prasad, Kishore Chandra Prasad & Shenoy, 2006).  
 
5.2.1.1. Oral phase difficulties  
The findings showed that difficulties with lip movement, tongue movement, strength and co-
ordination, oral transit and bolus clearance were noted in participants who had experienced a 
neurological condition such as CVA, meningitis and dementia being the most common 
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conditions. As oral movement is controlled by nerves and musculature, if there is a 
disturbance neurologically as a result of CVA or meningitis this can result in difficulties with 
oral movement.  This control involves the interplay of numerous sensory and/or motor cranial 
nerves as well as specific parts of the brain that are supplying information to the appropriate 
muscles of deglutition (Bass, 2006). Some participants who had oral manifestations such as 
candida and Steven Johnson Syndrome (SJS) also had difficulties with oral movement. 
Clayton and Kennedy (2007) reported that SJS can result in extreme pain and dysphagia and 
therefore reduced oral intake. This extreme pain can result in difficulty with oral movement. 
There is currently no literature that accounts for possible reasons as to why a participant with 
pulmonary TB could have oral phase difficulties. The findings from this study confirm the 
findings made in other studies such as Daly (2004) who states that oral phase difficulties are 
present in patients who are living with HIV/AIDS. This indicates that oral phase difficulties 
can arise from numerous causes in people who are living with HIV/AIDS.  
 
5.2.1.2. Pharyngeal phase difficulties  
The findings indicated that the majority of participants who experienced difficulties in the 
pharyngeal phase had a neurological condition. These findings are in agreement with 
literature. Langley (1993) and Logemann (1997) state that swallowing disorders occur in 
patients with numerous neuromuscular effects such as: CVA, head injuries, cranial nerve 
palsies, myopathies and degenerative diseases. The findings also revealed that participants 
who experienced odynophagia had candida and gastroenteritis. This is also similar to findings 
in other research ((Bhojwani, Chandra Prasad, Kishore Chandra Prasad & Shenoy, 2006).) 
which indicate that candida has been proven to lead to dysphagia and odynophagia in people 
who are living with HIV/AIDS. 
5.2.2. Is there a relationship between the diagnosis (neurological or opportunistic 
infections) of the patient and the severity of signs and symptoms of the dysphagia?  
 
In answering the question of whether there was a relationship between the participant’s 
diagnosis and the severity of the signs and symptoms of dysphagia, the following results were 
found that there were significant p-values for participants with a neurological condition for 
both the MASA (Mann, 2002) and MBS results. Findings from this study are supported by 
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those found by Roth (2001) and Ellis, Milford, Morton and Pinnington (2002) who stated that 
dysphagia is present in participants who have suffered a CVA.  Swallowing is a complex 
process that utilises 31 pairs of striated muscles (Bass, 2006).  The most common 
neurological condition identified in this study was CVA and the majority of these patients did 
experience a dysphagia. This is supported by current literature which states that if the cortex 
(posterior cortex and brainstem) is affected it will affect the overall swallowing physiology 
especially on muscle functioning such as in the case of neurological deficits (Bass, 2006). 
Therefore, the results indicate and imply that participants with a neurological deficit may 
experience more severe signs and symptoms of dysphagia as compared to participants who 
only present with an opportunistic infection.  
 
5.2.3. Is there a relationship between the variables of age, CD4 count & HAART regimen 
and the severity of the dysphagia? 
 
5.2.3.1. CD4 count 
In answering the above question, the following results were found: A significant relationship 
was found between a low CD4 count with respiration and voice quality. The results imply 
that the lower a participants CD4 count was, then the more severe their respiration and 
quality of voice were. As poor respiration from an upper respiratory tract infection can lead to 
a decrease in vocal quality and these results are therefore not unexpected (Hedge, 2001).This 
finding was interesting because literature states that in the final stages of the disease the 
patients are usually emaciated, with recurrent candida, herpes zoster as well as infections of 
the mouth, throat and oesophagus (Van Dyk, 2008). However, there were no studies that had 
found similar results. Based on these findings, it would be expected that these patients would 
have had more severe infections and therefore their swallowing ability would be more 
severely affected. This was however, not the case as seen in the data.  
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5.2.3.2. Age 
There was a significant relationship found between age and dysarthria and the oral phase. 
From the spread of ages in the data, the majority of participants were in their thirties. This is 
in agreement with the demographics of the HIV/AIDS population in South Africa which 
states that the majority of people who are living with the disease are in the age group of 
people who are typically employed. . Currently, no studies have focused on the effects that 
age has on dysphagia in people who are living with HIV/AIDS. Therefore this fact has 
implications for future research in the area.  
 
5.2.3.3. HAART regimen  
There was a significant relationship between HAART and pharyngeal phase, cough reflex 
and aspiration. The results revealed that participants who were on HAART had more severe 
pharyngeal phase difficulties, cough more frequently and aspirate more often. These results 
were surprising and differ from literature because as a patient commences HAART treatment, 
the course of the disease is altered as the patients have less frequent opportunistic infections 
(Arvieux et. al, 1998). There were however, no studies that specifically stated similar 
findings. Therefore, the result from this particular question does not support literature and 
implies that more research should be done in this area.  
 
5.2.4. Do the results of the MASA significantly correlate with the results of the MBS? 
When addressing the question of whether the results of the MASA (Mann, 2002)  correlate 
with the results of the MBS, the following results were found: the MASA (Mann, 2002)  and 
modified barium swallow results yielded significant correlations when it came to some 
measures and therefore the MASA could be used as a clinical tool in assessing dysphagia in a 
South African hospital context. It has significant clinical implications in that the MASA 
(Mann, 2002) can be used to assess dysphagia even when objective measures cannot be used. 
It also has implications in that future research needs to be conducted in this area.  
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5.3. Summary  
There have been numerous studies that have been conducted in the area of dysphagia but not 
specifically looking at the effects of HIV/AIDS, rather neurological disorders such as CVA 
(Hinds & Wiles, 1998; Bench, Perry & Scott, 1998; Burrel, et. al. (1998)). These authors 
have also only utilised one method of assessment for example a bedside assessment or an 
objective assessment such as FEES or VFS. This research has therefore focused on both 
methods of assessment in a developing country state hospital setting. The agreement that was 
reached between the MASA (Mann, 2002)  and the MBS results highlight the fact that the 
MASA was a valid tool in assessing dysphagia accurately at a bedside level. The MBS results 
were able to accurately assess whether a dysphagia was present in this population. The results 
that were obtained for this study therefore agree with the other literature such as Halvorsen et. 
al (1998) who suggests that objective measures such as VFS are important in assessing 
dysphagia in the HIV/AIDS population.  
 
However, as stated above, the majority of the research in this area has not been conducted by 
a SLP and a formal dysphagia assessment has not been performed. This research has been 
able to draw conclusions regarding dysphagia. A SLP can perform both bedside assessments 
as well as modified barium swallows in an assessment. 
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6. LIMITATIONS, IMPLICATIONS & CONCLUSION 
This research study has shown that dysphagia does occur in patients who are living with 
HIV/AIDS regardless of their co-morbid conditions, CD4 count, age and HAART regimen. It 
is therefore important that a SLP be involved in the assessment and management of these 
patients. However, it is also important that these patients need to be managed in a 
multidisciplinary team in order to improve patient management and their quality of life. 
Ideally, for a dysphagia assessment, both a subjective an objective test should be done. 
However, in developing countries it is not always possible for objective measures to be done. 
Therefore, this research has shown that the MASA can be performed as a bedside assessment 
because  it will yield accurate results.   
 
6.1. Limitations of the study  
A random error can affect the reliability of the results of the study. Random error is 
considered to be random disturbances in the performance on the measure (Durrheim et. al, 
2006). However, this was not evident in the Spearman Rho test that was performed.  The 
pitfall of a cross-sectional research design is that it does not analyse the population over a 
longer period and therefore, the changes of the population cannot be observed (Rosnow & 
Rosenthal, 2002).This study managed to yield some important results. However, for future 
research, a longitudinal research design could possibly be used. Another limitation was that 
there were only 26 participants that underwent a modified barium swallow. This was due to 
difficulties with the hospital x-ray equipment. A small number of participants may not yield 
such reliable results as a larger sample size would yield.  
 
6.2. Recommendations for future research  
 
There needs to be more research conducted in the field of HIV/AIDS and dysphagia such as: 
The specific effects of the different co-morbid conditions on dysphagia as compared to 
individuals who are HIV negative. In regards to the longitudinal effects of HAART on 
dysphagia, there is a need to compare the effects that the different HAART regimens have on 
dysphagia in people who are living with HIV/AIDS. Research is needed to conduct more 
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dysphagia assessments utilising both subjective and objective measures. More research needs 
to be done which looks at multidisciplinary team studies in the area of HIV/AIDS and 
dysphagia. This should include quality of life assessments in the area of dysphagia and 
HIV/AIDS. The ethical management of dysphagia in HIV/AIDS populations is also 
important. Based on the limitations of the study, longitudinal research needs to be conducted 
to evaluate the long term effects of HIV/AIDS on dysphagia in adults.   
 
6.3. Further recommendations 
It is recommended that perhaps the speech therapists who are working in the government 
sector need to create increased awareness of the role of the speech therapist in dysphagia in 
general as well as in dysphagia within the HIV/AIDS population. The MDT members that 
should be targeted are: doctors, dieticians, physiotherapists and occupational therapists. This 
is important in order to increase the number of referrals that are sent to speech therapists 
thereby improving patient management. As patient management improves, their quality of 
life will improve.  
 
Speech therapists should form part of the medical team that manage in and out patients who 
are living with HIV/AIDS. As this research study has concluded, the speech therapist has a 
vital role to play in the assessment and management of these patients.  
 
The effects of HIV/AIDS should be taught to undergraduate students. If the students have a 
good understanding of how HIV/AIDS can affect an individual, this would improve patient 
management when the students are in their community service year.  
 
Speech therapists should form part of the research team to assess the effects that HAART 
regimens have on a patient’s symptoms. South Africa has the largest population of people 
who are infected with the HI virus and therefore it is important that research be conducted in 
this environment.  
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6.4. Implications  
This research has therefore yielded important clinical results for the SLP practicing in South 
Africa. Dysphagia does occur in participants who are living with HIV/AIDS regardless of co-
morbid conditions, CD4 count, age and HAART regimen.  The MASA (Mann, 2002)  is a 
time effective and accurate bedside assessment tool for dysphagia and therefore it can be used 
in rural areas and in clinical settings where objective measures are unavailable. The SLP 
needs to be involved in the assessment and management of these patients in order to improve 
their quality of life. This study has also highlighted the importance of conducting future 
research in this area.  
 
6.5. Conclusion  
As stated previously, HIV/AIDS has become the world’s most serious public health problem 
(UNAIDS, 2009). South Africa has the highest HIV/AIDS population in the world. Therefore 
it is important that these studies be conducted in South Africa because SLP’s will be faced 
with these conditions as part of their everyday management.  Based on the literature that was 
reviewed for this study, it can be seen that dysphagia is prevalent in this population. 
However, insufficient studies have been conducted that specifically assess dysphagia. The 
results from this study have concluded that dysphagia is present in this population 
irrespective of co-morbid conditions, CD4 count, HAART regimen and age. It is therefore of 
great importance that the SLP in South Africa be involved in the multidisciplinary 
management of these patients in order to improve their quality of life. The Mann Assessment 
of Swallowing Ability (MASA) (Mann, 2002)  is a reliable assessment tool that the SLP in 
South Africa can utilise to assess dysphagia in their acute adult patients. As shown in this 
study, the area of HIV/AIDS is a significant topic for healthcare in South Africa and it is 
therefore vital that more research be conducted in order to improve our knowledge of how 
best to treat these patients.  
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Appendix C: Ethics Certificate (to come) 
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Appendix D: Patient Information Sheet  
Information Sheet for Informed Consent for Participation in Masters Research 
Hello,  
My name is Kim Alborough. I am doing my research for my Masters degree in Speech 
Pathology. I am interested in looking at the specific signs and symptoms of swallowing 
difficulties that people living with HIV/AIDS may experience. Hospital protocol is for me to 
do a bedside swallowing exam because the doctor has referred you to the speech therapy 
department. The bedside exam involves me assessing how you swallow with different types 
of food. If there is difficulty with your swallow, you will go for an x – ray where we watch 
how you swallow. I would need to use the results from these tests in the study.  
The implications of this study will be to improve the knowledge and skills of speech 
therapists that is needed for assessing a person who is living with HIV/AIDS.   
The information that will be used in the study will only be your age, diagnosis, CD4 count 
and the speech therapy assessment results.  
It is your right to refuse your results to be used in the study. You are allowed to withdraw 
your results from the study at any point. If you choose to withdraw, there will be no penalties 
or consequences.  
This knowledge that will be gained from this study will benefit the management of all future 
patients who are living with HIV/AIDS.  
If you agree to participate in my study, please sign the consent form which will allow me to 
use the results.  
Kindly note that in order to ensure confidentiality of your status, this information sheet 
is for your use only unless you choose to share this information. Please be careful what 
you do with this form.  
If you have any question, please do not hesitate to ask. My 24 hour contact details are (011) 
489 0823. The Human Research Ethics Committee details are: (011) 717 1234.  
Regards  
Kim Alborough 
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Appendix E: Stats assumptions of normality tables (to come) 
 
Age      Alertness 
 
Auditory comprehension   Respiration 
 
Dysarthria     Lip 
 
Tongue movement    Tongue strength 
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Tongue co-ordination   Oral preparation 
 
Gag      Palate 
 
Bolus clearance    Oral transit 
 
Cough     Voice 
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Tracheostomy   Odynophagia 
 
Multiple swallows   Poor laryngeal elevation 
 
Pharyngeal phase      Oesophageal phase 
 
Vomiting      Hiccups 
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Appendix F: Tables of different combinations of diagnoses  
  
Neurological condition with opportunistic infection   n  
CVA & Pulmonary Tuberculosis (PTB)     4 
Dementia and Candida        1 
Cryptococcal meningitis & Candida       1 
Confusion & liver dysfunction      1 
Candida & TBM        1 
Neurological condition with neurological condition    n  
CVA & CCM         3 
CCM & Tuberculosis meningitis (TBM)     1 
TBM & CVA         1 
Encephalitis & dementia        1 
Neurosyphillis & TBM       1 
Opportunistic infection with opportunistic infection   n 
PTB & Candida        1 
Gastro & TB         2 
Kaposi sarcoma & PTB       1 
Toxoplasmosis & TB        1 
TB & Candida  
Opportunistic infection with renal dysfunction     n  
Renal & TB         1 
Pneumonia & renal         1 
Gastro & renal         2 
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Appendix G: Tables of different HAART regimens  
 
HAART medication    n   Regime   % 
D4T/3TC/ EFV    6  1a   27 
TENOFIVIR/EFV/3TC   5  1a (1*)   23 
TENOFIVIR/3TC/NVP   6  1b (1^)   27 
TENOFIVIR/ 3TC/STAVUDINE  3     14 
EFV/AZT/3TC    1  1a (2*)   4.5 
EFV/3TC      1     4.5 
1* & 2*- different combinations of Regiment 1a  
1^ - different combinations of Regiment 1b.  
 
 
 
